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Zusammenfassung I
 
Zusammenfassung 
 
Seit einigen Jahren ist bekannt, dass Kaliumionenkanäle und Chloridionenkanäle sehr 
wichtig für die Zellproliferation und das Überleben von Krebszellen sind. Diese Ionenkanäle 
weisen eine unterschiedliche Aktivität auf, wenn man normalen Zellen mit Krebszellen 
vergleicht. 
Für in vitro Studien an Kaliumionenkanälen und dem mutmaßlichen Chloridionenkanal 
Bestrophin 1 (Best1) wurde die humane Kolonkarzinomzelllinie T84 benutzt. Die Expression 
unterschiedlicher Typen von Kaliumionenkanälen konnte durch RT-PCR gezeigt werden. 
Aber nur spannungsabhängige Kaliumionenkanäle (Kv Kanäle) hatten einen Einfluss auf die 
Zellproliferation. Messungen von Zellvolumen, intrazellulären pH und 
Kalziumionenkonzentration zeigten, dass Kv Kanäle den intrazellulären pH und das 
Kalziumsignal die Zellproliferation kontrollieren. Sie haben aber keinen Einfluss auf die 
Volumenregulation. 
In weiteren Zellkulturexperimenten konnten zwei unterschiedliche Klone von T84 Zellen 
generiert werden: ein langsam wachsender Klon (T84-slow) und ein schnell proliferierender 
Klon (T84-fast). Die Expression des Kv Kanals Eag1 und des mutmaßlichen 
Chloridionenkanals Best1 war im Vergleich zu T84-slow in T84-fast erhöht. Die ATP induzierte 
Erhöhung der intrazellulären Kalziumionenkonzentration war in T84-fast ebenfalls erhöht, was 
auf die Zunahme der Aktivität von Kv Kanälen zurückgeführt werden kann. Kv Kanäle haben 
die Aufgabe das Membranpotential der Zellen zu hyperpolarisieren, was zu einem erhöhtem 
Einstrom von Kalziumionen in die Zelle führt, welches wiederum zum Durchlaufen des 
Zellzyklus bei der Zellteilung notwendig ist. Die Hemmung der Expression von Eag1 oder 
Best1 durch RNAi hatte eine verminderte Zellproliferation zur Folge. Des Weiteren führte 
eine Überexpression eines Best1-Plasmids in T84-slow zu einer 30%igen Steigerung der 
Proliferationsrate und zu einer verbesserten Volumenregulation. Diese Experimente zeigen, 
dass sowohl Eag1 als auch Best1 eine wichtige Rolle bei der Proliferation von 
Kolonkarzinomzellen spielen. 
Im zweiten Teil dieser Arbeit wurden in vivo Experimente im Tiermodell durchgeführt. Die 
molekularen und funktionellen in vitro Befunde aus der Zellkultur wurden zuerst in einem 
chemischen Mausmodell für Kolonkarzinom überprüft. Dafür wurden BL6-Mäuse mit den 
karzinogenen Substanzen Dimethylhydrazine (DMH) und N-methyl-N-nitrosourea (MNU) 
behandelt, um die Entstehung von Kolonkarzinom zu induzieren. Die so behandelten Mäuse 
zeigten einen verminderten elektrogenen Salztransport durch den epithelialen 
Natriumionenkanal ENaC und den Chloridionenkanal CFTR. Zusätzlich konnte eine erhöhte 
Aktivität von Kv Kanälen nachgewiesen werden. Semiquantitative PCR zeigte schon in den 
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ersten Wochen nach der Behandlung eine erhöhte Expression von den Kv Kanälen Kv1.3, 
Kv1.5, Kv3.1, Eag1, Elk1 und Erg1. Parallel dazu wurden Proteinexpressionsnachweise 
durch Western Blots für Eag1 durchgeführt. Es konnte eine Erhöhung von Eag1 auch auf 
Proteinebene nachgewiesen werden. Weiterhin konnte durch eine Kooperation mit einer 
Arbeitsgruppe in Basel eine genomische Amplifikation von Eag1 in 3,5% der untersuchten 
humanen kolorektalen Adenokarzinome mittels Fluoreszenz in situ Hybridisierung gezeigt 
werden. 
Eine zweite tierexperimentelle Studie wurde in einem genetischen Mausmodell durchgeführt. 
BL6-Mäuse mit einer Mutation in dem Tumorsuppressorgen APC (APC-Min/+) entwickeln 
während ihres Lebens Polypen im gesamten Darmtrakt. APC-Min/+ Mäuse zeigten einen 
signifikanten Gewichtsverlust und eine verkürzte Lebensspanne während der 
Beobachtungsperiode von 21 Wochen. Durch real time PCR konnte eine erhöhte mRNA 
Expression des Kv Kanals Eag1, des kalziumionenaktivierten Kaliumionenkanals BK und des 
Natriumionenkanals ENaC nachgewiesen werden. Messungen des epithelialen Transportes 
durch Ussingkammertechnik zeigten eine erhöhte Natriumionenabsorption durch ENaC und 
verstärkte Aktivität von BK- und Eag1-Kaliumionenkanälen. 
Zusammenfassend kann gesagt werden, dass die Aktivität von Kv Kanälen der Kv 
Ionenkanalfamilien Kv1, Eag oder BK, sowohl in vitro als auch in vivo direkt mit der 
Zellproliferation und Krebsentwicklung korrelieren. Diese Kanäle könnten damit als wichtiges 
Ziel für Diagnose und Behandlung von Kolonkarzinom dienen. 
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Summary 
 
As shown in the past potassium ion channels (K+ channels) and chloride ion channels (Cl- 
channels) are important for proliferation and survival of cancer cells. These ion channels are 
differentially activated in cancer cells compared to normal tissue or cells. 
The human colonic cancer cell line T84 was used for in vitro studies on K+ channels and the 
putative Cl- channel Bestrophin 1 (Best1). The expression of many different K+ channel types 
was screened by RT-PCR. However, only voltage-gated (Kv) channels have an impact on 
cell proliferation. Measurements of cell volume, intracellular pH, and intracellular Ca2+ 
concentration demonstrate that Kv channels control proliferation by affecting intracellular pH 
and Ca2+ signaling, but not by cell volume regulation. 
In further cell culture experiments two different clones of T84 cells were generated: a slow 
proliferating clone (T84- slow) and a fast proliferating clone (T84- fast). Expression of the Kv 
channel Eag1 and the putative Cl- channel Best1 was enhanced in T84- fast as compared to 
T84- slow. ATP-induced enhancement of the intracellular Ca2+ concentration was increased in 
T84- fast, indicating that Kv channels hyperpolarize the cell membrane and therefore enhance 
the driving force for Ca2+, which is necessary for cell cycle progression. Down regulation of 
Eag1 or Best1 by RNAi decreased cell proliferation in T84-fast. Furthermore, Best1 over 
expression in T84-slow increased the proliferation rate by 30% and improved cell volume 
regulation. These experiments demonstrate that Eag channels and Best1 have an important 
role in proliferation of colonic cancer cells. 
For the second part of this study the role of Kv channels in colonic cancer was evaluated in 
vivo in an animal model. The molecular and functional expression of these ion channels 
found in vitro in T84 cells were examined first in a chemical mouse model. For this purpose 
BL6 mice were treated with the chemical carcinogens DMH and MNU to induce the 
development of colonic cancer and to investigate ion channel properties in early stages of 
carcinogenesis. In carcinogen treated mice electrogenic salt transport by the epithelial 
sodium channel ENaC and the chloride channel CFTR were attenuated. In addition, activity 
of Kv channels was enhanced. Already in the first weeks after treatment semi-quantitative 
PCR showed an mRNA upregulation of the Kv channels Kv1.3, Kv1.5, Kv3.1, Eag1, Elk1, 
and Erg1. At the same time an increased Eag1 protein expression could be demonstrated. 
Furthermore, in cooperation with a group in Basel a genomic amplification of Eag1 was found 
in 3.5% of human colorectal adenocarcinomas identified by fluorescence in situ hybridization 
analysis (FISH). 
A second in vivo study was performed in a genetic mouse model of colonic cancer. BL6 mice 
with a mutation in the tumor suppressor gene APC (APC-Min/+) develop polyps in the whole 
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intestine. These APC-Min/+ mice showed a significant weight loss and a reduced lifespan 
during an observation period of 21 weeks. An increased mRNA expression of the Kv channel 
Eag1, the Ca2+ sensitive Kv channel BK and the sodium channel ENaC could be detected by 
real time PCR. Ussing chamber studies demonstrated an enhanced sodium absorption by 
ENaC and an enhanced activity of BK and Eag1 channels. 
In summary activity of Kv channels like members of Kv1, Eag, or Ca2+ sensitive BK showed a 
direct correlation to cell proliferation and cancer development in vitro and in vivo. These 
channels may represent an important target for diagnosis and novel therapeutics of colonic 
cancer. 
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Chapter 1 
 
 
General Introduction 
 
In the western world colorectal cancer (CRC) is the most malignant death-causing disease, 
besides tumors caused by smoking. Nearly 50% of the population in developed countries has 
colorectal tumors by the age of 70. CRC is characterized by several intermediate stages 
ranging from small adenomas to large metastatic carcinomas, which require decades to fully 
develop. Progression from normal healthy colonic epithelia to malignant colonic cancer is 
well described as a genetic model, where at least seven different series of genetic alterations 
have to occur (1-3). 
 
But not only genetic disorders have an impact on the severity of the disease, environmental 
factors such as diet may also play an important role. There is a remarkable 20-fold difference 
in CRC-incidence worldwide between western world populations and populations in 
developing countries, who have a lower risk to develop colonic cancer. Dietary fat intake, 
with the main source being red meat, has positive effects on tumor development and 
enhances the risk of developing colonic cancer (4). In the next few years the number of CRC 
will increase even more due to a Western life style, which often includes a diet consisting of 
high consumption of fast food and lack of sufficient physical activity. Because there is a high 
likelyhood for rising numbers of colonic cancer cases and the malignancy of the disease new 
therapies and diagnostic methods are needed. 
 
1.1 Ion channels and cell proliferation 
Ion channels are present in the cell membrane and in intracellular membranes of every cell 
type, not only in excitable tissues like neuronal or muscle cells. Ion channels exist for the four 
ions potassium (K+), sodium (Na+), chloride (Cl-), calcium (Ca2+), and many more. Membrane 
ion channels can be activated either by ligands (ligand-gated ion channels) or changes in the 
membrane potential (voltage-gated ion channels), usually depolarization. The ion conducting 
pore of a channel is more or less selective for its specific ions. Most voltage-gated ion 
channels are highly selective, some ligand-activated ion channels allow more than only one 
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type of ion to enter the ion channel pore (5). The most important roles of ion channels are 
maintaining the cell membrane potential and controlling cellular parameters like Ca2+ 
signaling, ion concentration, and intracellular pH. Cells have to keep their cell volume to a 
certain level, even though they need to adapt to changing conditions during proliferation. As 
ion channels have such an important impact on proliferation and survival, it is not surprising 
that they might also play a crucial role in diseases (6). Disorders caused by altered or loss of 
individual ion channel function or alterations in the channel density are generally called 
channelopathies. Tumor development could also be due to changes of ion channel function, 
which could transform healthy epithelia to a malignant, invasive, and fast growing tissue. 
 
1.2 The human colonic epithelium 
The mammalian colonic epithelium consists of three different cell types with distinct 
functions. 95% of all intestinal cells are columnar epithelial cells (enterocytes) and mucus-
producing goblet cells. The remaining 5% are enteroendocrine cells required for hormone 
production (7). One way to enhance the surface in the colon is the organization of epithelial 
cells in crypts (Fig. 1-1). The left part of figure 1-1 shows that the intestinal epithelium is 
constantly regenerated from stem cells in the colonic crypt base. The epithelial cells 
differentiate during migrating from the crypt to the surface along the crypt axis. The 
differentiated surface enterocytes undergo apoptosis and are shed to the intestinal lumen. 
The whole process is completed within 3-5 days (8). 
 
The main function of the colonic epithelium is net absorption of electrolyte. Every day 
approximately 1.3 – 1.8 liters of electrolyte-rich fluid is absorbed (9). Beside absorptive 
properties the epithelium is also a secretory tissue when stimulated by secretagogoues. 
Therefore, colonic epithelial cells are polarized and equipped with ion channels, transporters, 
carriers, and pumps (Fig. 1-1) located either on the luminal or basolateral side of the 
membrane. These transporters are responsible for the highly efficient transport of large 
amounts of salt and water. Depending on their localization, cells in the colonic crypt have 
different transport properties. Epithelial cells in the crypt base have a high proliferative and 
Cl- secretory activity due to high CFTR conductance. Surface epithelial cells are fully 
differentiated, have no tendency to proliferate, and show a primarily absorptive behavior due 
to high epithelial sodium channels (ENaC) activity when compared with basal crypt cells (10, 
11). Epithelial cells build a low- resistance epithelium of about 100 Ω·cm² in the proximal 
colon and a two- to fourfold higher resistance epithelium in the distal colon. 
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1.3 Ion channels in human colonic cancer 
During tumor development the proliferative zone expands and therefore ion channel and 
transport protein expression pattern change along the crypt axis. As shown on the right panel 
of figure 1-1 colonic carcinoma cells never gain the ability to absorb Na+ (less ENaC) and 
increased Cl- secretion is due to high activity of CFTR and additionally atypical Cl- channels 
like Ca2+ activated chloride channels (CaCC) are activated (7). 
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Fig. 1-1 Cellular model of colonic epithelium and the expression of ion channels and 
transport proteins in the crypt during tumorigenesis (adapted from 7, 12) 
In crypts of colonic tumors the proliferative zone is expanded. The expression pattern of 
diverse ion channels and transport proteins are either up (larger letters) or down regulated 
(smaller letters). Due to changes in ion channel and transporter expression and therefore 
in their activities the colonic epithelium evolves during cancerogenesis from an absorptive 
to a more secretory phenotype. ENaC = epithelial sodium channel, CFTR = cystic fibrosis 
transmembrane conductance regulator, DRA = down regulated in adenoma, NKCC1 = 
Na+- 2Cl-- K+ cotransporter type 1, Glut1 = glucose transporter type 1, MDR-1 = multi drug 
resistance protein 1, CaCC = Ca2+ activated chloride channels 
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1.4 K+ channels and cancer 
Over the last years the most intensively studied ion channels with regard to proliferation and 
tumor development were K+ channels. K+ channels are the most diverse class of ion 
channels expressed in the cytoplasmic membrane. They are classified in four families based 
on their structural relatedness and predominant functional characteristics: voltage-gated (Kv), 
calcium-activated (KCa), two-pore (K2P), and inward rectifier (Kir) potassium channels. All 
families are further subdivided into subfamilies (13). Increased expression of members of 
almost all K+ channel families can be found in tumors and tumor cell lines (Table 1-1). 
 
Table 1-1 Expression of K + channels in cancer cell lines or tumors (adapted from 14) 
Examples of K+ channels, which are upregulated in cancer cell lines or tumor tissues. 
 
 
family 
 
subfamily 
 
members 
 
type of tumor cell line 
 
type of tumor 
 
Kv channels 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KCa channels 
 
 
K2P channels 
 
 
 
 
 
 
Kir channels 
 
 
Kv1 
 
 
 
Kv3 
 
 
Kv10 
 
 
 
Kv11 
 
 
 
Kv12 
 
 
BKCa 
 
 
K2P 
 
 
KATP 
 
 
 
Kir 
 
 
Kv1.3, 
Kv1.5 
 
 
Kv3.3, 
Kv3.4 
 
Eag1 
Eag2 
 
 
Erg1 
 
 
 
Elk1, 
Elk2 
 
BK, SK 
 
 
TWIK 
TASK 
 
KATP 
 
 
 
Kir 4.1 
 
 
prostate cancer cells, 
colonic cancer cells 
 
 
 
 
 
NIH 3T3, HeLa 
 
 
 
atrial tumor cells (HL-1), 
breast cancer cells (SK-
BR-3), colonic cancer 
cells 
 
 
 
prostate cancer cells 
(PC3) 
 
melanoma cell line (SK-
MEL-28) 
 
liver epithelial cell lines 
(HepG2, HuH-7, HFL), 
U-373 MG, SK-N-MC 
 
neuroblastomaxglioma 
hybrid cells (NG108-15), 
basophilic leukemia cells 
(RBL-2H3) 
 
 
neuroblastoma, breast carcinoma, small lung 
cell carcinoma, melanoma, lymphoma, 
hepatocarcinoma 
 
colonic carcinoma 
 
 
cervix carcinoma, neuroblastoma, mammary 
gland carcinoma, ductal carcinoma, breast 
carcinoma 
 
myeloid leukemia, neuroblastoma, colorectal 
cancer 
 
 
astrocytoma 
 
 
glioma, pituitary GH3 lactotroph 
 
 
glioma, neuroblastoma, medulloblastoma, 
leukemia, insulinoma 
 
astrocytoma, neuroblastoma, insulinoma, 
urinary bladder carcinoma, medulloblastoma 
 
 
 
 
 
More than 10 years ago, Wonderlin and Strobl reviewed the potential role of ion channels for 
cell proliferation. Several experiments in different cell lines show that specific types of K+ 
channels must be activated for progression through the different phases of the cell cycle. 
Treatment of mitogen-stimulated T- and B-lymphocytes with inhibitors of endogenous K+ 
channels decrease proliferation and arrest the cells in early G1 phase. The main function of 
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K+ channels during cell cycle is their hyperpolarizing effect on membrane voltage and 
therefore their impact on Ca2+ signaling. Ca2+ influx is stimulated by hyperpolarization of the 
membrane potential, which is required at three check points in the cell cycle (Fig. 1-2). An 
increased intracellular Ca2+ concentration is needed during progression through G1 phase 
and the G1/S transition (6, 15). 
 
Kv, KCa, Kir
KCa
Kv
G1 check point
G2 check point
Metaphase check point
Cyclin E
Cyclin A
Cyclin B
 
 
Fig. 1-2 Activity of K + channels during the cell cycle (15) 
During cell cycle activity of K+ channels is required to hyperpolarize the cell membrane 
and therefore maintain the driving force for Ca2+ influx into the cell. Kv = voltage activated 
K+ channels, KCa = Ca2+ activated K+ channels, Kir = inwardly rectifier K+ channels, G1 = 
gap phase 1, S = DNA synthesis phase, G2 = gap phase 2, M = mitosis 
 
During G1/S transition and S phase cells swell and activate a regulatory volume decrease 
(RVD) mechanism, which allows shrinkage of the cell after mitosis. RVD requires efflux of 
water and solutes, which is due to simultaneous opening of K+ and Cl- channels. Blocking of 
K+ channels leads to inhibition of RVD. Tumor cells have an optimized RVD leading to better 
growth conditions compared to normal cells. However, excessive and early activation of K+ 
and Cl- channels inhibit proliferation and furthermore lead to cell shrinkage and promote 
apoptotic cell death (6). 
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1.5 Eag: a cell cycle regulated K+ channel with oncogenic properties 
K+ channels from the ether-á-go-go (Eag) type are regulated by cell cycle. These channels 
are further subdivided into three subfamilies: Eag, Eag-related (Erg), and Eag-like (Elk) 
channels. Eag channels are predominantly active in the early G1 phase (6, 16). Activation of 
these K+ channels causes oscillations of the membrane potential, which may regulate cell 
cycle-dependent proteins, like the cyclin-dependent kinase inhibitors p27 and p21. They 
accumulate due to inhibition of K+ channels and membrane depolarization (17). However, a 
causal relationship between the function of Eag K+ channels and membrane voltage in 
specific cell cycle phases and cell cycle-dependent cellular processes like proliferation and 
differentiation is still unknown (18). Nevertheless it is shown that Eag channels have an 
oncogenic potential on cells and in severe combined immune-deficient (SCID) mice. Pardo’s 
group demonstrated the presence of Eag mRNA transcripts in the human breast carcinoma 
cell line MCF-7, while this has not detected in normal human breast tissue. Eag is also 
expressed in several other tumor cell lines like the cervix carcinoma cells HeLa, the 
neuroblastoma cell line SH-SY5Y, and different mammary gland carcinoma cells. In Eag-
expressing cancer cell lines Pardo et al. showed that inhibition of Eag channels by Eag-
specific antisense oligomers decrease proliferation. Moreover, when Eag-transfected chinese 
hamster ovary cells (CHOhEag) are subcutaneously implanted into SCID mice, all of these 
mice developed tumors (14, 19). Both Erg mRNA and protein have been detected by many 
groups in tumor cell lines and in primary human cancers. Some examples are endometrial 
adenocarcinomas, acute myeloid and lymphoid leukemia (20-24), many colonic cancer cell 
lines, and primary colorectal tumors including metastatic cancers (Table 1-1). In addition Erg 
channels are involved in the establishment of a very invasive phenotype in colorectal cancer 
cells (16). With regard to their function in the cell cycle Erg channels modulate the 
progression through the M phase, when the cellular membrane voltage is more depolarized. 
Little is known about Elk channels. Elk channels are primarily expressed in the nervous 
system and are also found to be enhanced in tumors of the brain (25). 
 
1.6 Genetic alterations in the development of colorectal cancer 
In general tumorigenesis requires several mutational steps. Furthermore, many additional 
genetic alterations have been found and other routes like epigenetic pathways are also 
detected. For colorectal carcinogenesis two major genetic pathways are documented: 
microsatellite instability (MSI) and chromosomal instability (CIN) (26). 
 
The hereditary nonpolyposis colorectal cancer (HNPCC) syndrome is a special type of CRC. 
It is a simple Mendelian disease where the chromosomes 2p16 or 3p21 are involved (27-30). 
Mutations in the human homologs of mismatch repair (MMR) genes mutS or mutL are 
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responsible for this hereditary disease. Approximately 65% of sporadic colonic cancers carry 
these two MMR gene mutations as well (3).Tumors of HNPCC patients have a high genome-
wide instability of their repair system or in the microsatellites - MSI. Microsatellites are 
tandem-repetitive, short, simple DNA sequences consistent of 10 to 100 nucleotides. MSI 
can be described as an expansion in the number of tandem repeats. In MSI positive tumors 
other additional microsatellite mutations for the following target genes resulting cytokines, 
oncogenes, cell cycle controlling genes, and apoptosis have been identified: 
? TGF- β (transforming growth factor-β), inhibition of cell growth 
? PTEN (phosphatase and tensin homolog deleted on chromosome 10), inhibition of 
cell growth 
? BAX, induces apoptosis 
? E2F-4, control of progression through the cell cycle (26) 
 
Figure 1-3 describes the CIN pathway of colorectal carcinogenesis. It is a multi step mutation 
process, where allelic losses on chromosome 5q (adenomatous polyposis coli - APC), 18q 
(DCC/SMAD4), and 7p (p53) occur. Mutations in the APC gene are very early events during 
the development of cancer. At the adenomatous stage K-ras mutations arise and as a last 
step to malignancy mutations of p53 and deletions on chromosome 18q occur (31). 
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other
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Fig. 1-3 Genetic alterations during colorectal tumorigenesis (3) 
Loss of function mutations of APC are the initial step of the neoplastic process and cause 
benign adenoma. Afterwards alterations of the oncogene K-ras occur. These are gain of 
function mutations and require only one genetic event for activation. Other subsequent 
mutations like DCC/SMAD4 and p53 leading to malign stages of CRC as indicated in this 
figure. ACF = aberrant crypt foci 
 
This pathway illustrates nicely the three different gene classes important for the development 
of colonic cancer. Mutations in these genes lead to neoplastic transformation: oncogenes 
(“gain-of-function” mutations), tumor suppressor genes (“loss-of-function” mutations), and 
DNA repair genes. Failures during DNA replication or DNA damages are corrected by DNA 
repair mechanisms, which are encoded by DNA repair genes. If mutated, non-functional 
gene products are expressed, which then leads to diseases or formation of cancer like 
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HNPCC? Mutations in oncogenes generally cause unlimited cellular proliferation and 
inhibition of apoptosis. Over expression or aberrant expression of the normal gene product, 
or expression of an altered protein cause constitutive activation of oncogenes. The class of 
oncogenes contains members of a wide variety of genes including p53, the cytoplasmic 
second messenger ras, transcription factor myc, and growth factor wnt. Normally, tumor 
suppressor genes are responsible for inhibition of cell growth, stimulation of differentiation, 
and active cell death. At this time more than a dozen tumor suppressor genes have been 
identified. A few examples for these genes associated with cancer are PTEN, retinoblastoma 
rb1, Wilms’ tumor wt-1, neurofibromatosis type 1 nf-1, and APC (32, 33). 
 
1.7 APC and cancer 
Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited disease where 
patients develop hundreds to thousands of benign adenomatous colorectal tumors during 
their second and third decade of life. Out of the large number of polyps some will progress 
into invasive cancers and will finally metastasize. The genetic defect causing FAP are germ 
line mutations of the APC gene. 
 
The APC gene is localized on chromosome 5q21-q22 and encodes a 312 kDa protein 
product. APC is expressed in a variety of tissues and organs during embryonic development 
and in adulthood. It is a multidomain protein and binds to a number of other proteins, 
indicating various functions in the cell. Therefore the APC protein can be detected in the 
cytoplasm, but it can also accumulate in the apical membrane, along the lateral margins of 
epithelial cells, and in the nucleus. APC is a tumor suppressor gene and its major cellular 
functions are: 
? binding to β-catenin, which is necessary for adhesion, migration, and movement of 
enterocytes in the crypt 
? down regulation of the Wnt signaling pathway, which results in inhibition of cell 
proliferation (tumor suppressor function) 
? control of the cell cycle by regulation of the progression through mitosis 
? control of apoptosis (12, 33-36) 
 
The APC protein contains several distinct domains (Fig. 1-4): an oligomerization domain and 
an armadillo domain at the N-terminus; in the middle part three 15- and seven 20- amino acid 
repeats; at the C-terminus a basic domain, and binding sites for DLG (mammalian 
homologue of Drosophila tumor suppressor discs large), EB1 (end-binding protein 1), and 
PTP (protein tyrosine phosphatase) (12). 
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Fig. 1-4 Structure of the APC protein and its binding sites (33) 
APC is a 312 kDa protein and contains multiple binding sites and domains. Arrows 
indicate the binding sites. APC-binding proteins are in yellow. NES = nuclear export 
signal, Arm = armadillo, PP2A = protein phosphatase 2A, Asef = APC-stimulated guanine 
nucleotide exchange factor, aa = amino acid, SAMP = serine arginine methionine proline, 
NLS = nuclear localization signal, DLG = Drosophila tumor suppressor discs large, EB1 = 
end-binding protein 1, PTP = protein tyrosine phosphatase 
 
The N-terminal oligomerization domain of the APC protein is necessary for homomerization. 
Binding of proteins at the armadillo repeats leads to interactions of APC with actin and the 
microtubule cytoskeleton, causing changes in cell morphology, motility, migration, and cell 
division. Proteins binding at the armadillo domain are: 
? ASEF (APC-stimulated guanine nucleotide exchange factor), when activated it is 
involved in rearrangement of the actin network 
? PP2A (protein phosphatase 2A), binds with its catalytic subunit to axin 
? KAP3 (kinesin superfamily-associated protein 3), a mediator between APC and 
kinesin motor proteins 
 
The three 15-amino acid repeats and seven 20-amino acid repeats in the central part of APC 
serve as β-catenin binding sites. Binding of APC to β-catenin down regulates the Wnt 
signaling pathway and lead to formation of large protein complexes with β-catenin and axin. 
Ubiquitin-mediated degradation of β-catenin is due to phosphorylation of axin by GSK3β 
(glycogen synthase kinase 3β). Another axin-binding site is the SAMP (serine arginine 
methionine proline) sequence. At the basic domain APC binds to microtubules and 
stimulates tubule growth and their elongation by tubulin polymerization. The C-terminus 
contains a binding region for the following proteins: 
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? EB1, a microtubule plus-end binding protein, associating with centromere, mitotic 
spindle 
? DLG, binding leads to interactions with cytoskeleton proteins, may promote 
localization of APC to higher order protein complexes, and suppresses the G1/S 
progression in the cell cycle 
? PTP (12, 35) 
 
By interacting with actin, microtubules and β-catenin, APC integrates structural components 
of the cell, as the cytoskeleton and the spindle apparatus with one of the major signal 
transduction pathways, the wnt/hegdehog/notch pathway. APC thereby influences cell cycle 
progression, division, migration and cell shape/structural integrity, which are all processes 
deregulated in carcinogenesis. 
 
Somatic mutations of the APC gene are concentrated in a central region of the open reading 
frame (mutation cluster region, Fig. 1-4) between codons 1286 and 1513. This region is 
located in the middle part of the protein. Germ line mutations are confined to the 5´end of the 
APC gene. Most of the mutations are C to T transitions resulting from cytosine methylation. 
One of these transitions changes the codon CGA to TGA, a stop codon leading to expression 
of a truncated protein, which is only half the size of wt protein (Fig. 1-4). Deletion of parts of 
the protein leads to less protein-protein interactions due to the missing binding domains in 
the N-terminus. Nevertheless, the truncated APC protein has still domains for β-catenin 
binding and an oligomerization domain leading to dimerization with a wt or a second 
truncated APC protein. β-catenin binding to the truncated APC protein results in 
accumulation of β-catenin in the cytoplasm and nucleus as observed in cancer cells and in 
colorectal adenomas of FAP patients. This β-catenin accumulation is an important event in 
cellular growth control by providing stable interactions of β-catenin with: 
? cadherins 
? APC 
? EGF (epithelial growth factor) receptor 
? TCF/LEF (T-cell factor / lymphoid enhancer factor) 
 
In conclusion, mutations in the APC gene lead to inappropriate and continuous transcription 
of target genes. Functionally, it results in the lost of the tumor suppressor activity of APC 
characterized by less differentiation and apoptosis, disorganization of the cytoskeleton of 
epithelial cells, chromosomal instability, and influences the cell cycle regulation leading to the 
development of cancer (8, 12, 33, 35). 
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1.8 Mouse models of colorectal cancer 
Mutations in the APC gene are correlated to carcinogenesis in the human colon. Mouse 
models are powerful systems for studying direct molecular interactions in diseases and to 
find methods for diagnosis or treatment. For colorectal cancer both exist, genetic and 
carcinogen induced mouse models. 
 
DMH is a well known chemical used to induce tumors in rodents and have been the favored 
animal model for CRC in the last years. DMH is a procarcinogen that undergoes a series of 
chemical transformations in the gastrointestinal (GI) tract. After metabolization of DMH the 
carcinogen methyldiazonium ion is generated. This ion forms a methyl carbonium ion, which 
is responsible for methylations of macromolecules like DNA (37). The model has the 
disadvantage that tumor development is variable, depending on the mouse strain. 
Additionally, tumors generated by DMH have different mutations (only rarely APC gene 
mutations, and no p53 allelic loss), compared to those appearing in human CRC (4). In order 
to have a mouse model available with a mutation similar to that in human CRC, the APC 
mouse has been developed. 
 
The APC-Min/+ mouse (developed by Moser et al. in the 1990s) was generated by using the 
mutagen ethylnitrosourea (ENU). It is a genetic model for the human FAP disease. Multiple 
intestinal neoplasia (Min) mice carry a nonsense mutation in exon number 15 of the APC 
gene leading to a truncated APC protein of 95 kDa. In the homozygous form, this mutation is 
embryonic lethal, while heterozygotes are viable, but with a reduced lifespan. To breed these 
mice heterozygote males and wildtype females have to be mated. The Min mutation cannot 
be propagated through heterozygote females, because anemia and intestinal adenomas 
interfere with pregnancy and they would die during pregnancy. APC-Min/+ mice have a fully 
penetrant dominant phenotype and develop numerous intestinal and colonic polyps, and die 
approximately four month after birth due to severe progressive anemia, rectal prolapse, 
and/or intestinal obstruction (38, 39). The number of adenomas depends on the genetic 
background. Compared with the C57BL/6J (BL6) strain, other mouse strains seem to be less 
sensitive to the Min mutation. This is probably caused by existing alleles, which lower the 
tumorigenic effect of Min, namely Mom-1 (modifier of Min) (4, 40). APC-Min/+ mice with BL6 
background have more tumors than AKR, MA, and CAST back grounded mice. 
 
General Introduction 12
 
1.9 Aims of the present study 
 
In many different cancer cell lines and cancerous tumors K+ channels are over expressed. 
The mechanisms, however, how these K+ channels modulate cell proliferation remain 
investigated. A major goal of the present study was to investigate, which types of K+ 
channels are expressed in the human colonic cancer cell line T84 and/or how they influence 
cell proliferation. Studies on intracellular Ca2+, pH, and cell volume in presence and absence 
of K+ channel inhibitors and RNAi should help to clarify the contribution of K+ channels to cell 
proliferation. Secondly, two mouse models of colorectal cancer were used. In one model, 
tumors were induced by the carcinogen DMH or its analogue MNU. In addition, we made use 
of the genetic APC-Min/+ model. Changes in electrolyte transport during the development of 
colonic cancer were investigated by Ussing chamber techniques and rectal potential 
difference measurements. K+ channel mRNA expression from isolated mouse colonic crypt 
cells were analyzed by quantitative real time PCR and protein expression was examined by 
western blotting and immunocytochemistry. These experiments suggest an impact of K+ 
channels in precancerous stages and developing colonic tumors. 
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Chapter 2 
 
 
Eag1 and Bestrophin 1 are upregulated in fast growing colonic cancer cells 
 
Abstract 
 
Ion channels like voltage gated ether á gogo (Eag1) K+ channels or Ca2+ activated Cl- 
channels have been shown to support cell proliferation. Bestrophin 1 (Best1) has been 
proposed to form Ca2+ activated Cl- channels in epithelial cells. Here we show that original 
T84 colonic carcinoma cells grow slow (T84-slow) and express low amounts of Eag1 and 
Best1, while spontaneously transformed T84 cells grow fast (T84-fast) and express high levels 
of both proteins. Both Eag1 and Best1 currents are upregulated in T84-fast cells. Eag1 
currents were cell cycle dependent, with an up regulation during G1/S transition, thus 
confirming its property as a cell cycle regulated K+ channel in colonic cancer cells. RNAi 
inhibition of Eag1 and Best1 reduced proliferation of T84-fast cells, while over expression of 
Best1 turned T84-slow into fast growing cells. Eag1 and Best1 improve intracellular Ca2+ 
signaling and cell volume regulation. These results establish a novel role of bestrophins for 
cell proliferation. 
Eag1 and Bestrophin 1 are upregulated in fast growing colonic cancer cells 14
 
Introduction 
 
An increasing number of studies demonstrate proliferative effects of membrane ion channels 
(14). Voltage gated K+ channels and other types of K+ channels are expressed in numerous 
types of tumors, where they may serve as diagnostic and prognostic markers and potential 
drug targets (41-43). Eag1 channels are probably necessary for progression through the G1 
phase and G0/G1 transition of the cell cycle (15). A recent study demonstrates the 
hyperpolarizing effects of Eag1 and other Kv channels on the membrane voltage of T84 cells, 
which supports intracellular pH regulation and Ca2+ increase, necessary for proliferation (44). 
Much less is known about the role of Ca2+ activated Cl- channels for cell proliferation (6). This 
may be due to the ongoing controversy regarding the molecular nature of Ca2+ activated Cl- 
channels (45). A family of putative Ca2+ activated Cl- channels (CLCA) has been identified, 
which also controls cell-cell adhesion, apoptosis and cell cycle. However, their structure and 
biophysical properties are poorly understood (46, 47). Recent studies defined bestrophin 
proteins as bona fide Ca2+ activated Cl- channels. The Cl- currents generated upon 
expression of bestrophin show many of the properties found for native Ca2+ activated Cl- 
currents (48-50). However, bestrophins have also been proposed to function as regulators of 
voltage gated L-type Ca2+ channels (51). Our own ongoing work in epithelial cells supports 
both concepts in that bestrophins may form part of a Cl- channel complex or may couple 
intracellular Ca2+ signals to Cl- channels of unknown molecular identity (52). 
In the present report we demonstrate that both voltage gated Eag1 K+ channels and 
bestrophin (Best1) Cl- channels support proliferation of fast growing T84 colonic carcinoma 
cells. The fast growing T84 cell clone was obtained through a spontaneous transformation of 
slow-growing T84 cells. In contrast to slow growing T84 cells, transformed cells do not form 
polarized monolayers and show a remarkable up regulation of Eag1 and Best1 expression. 
We demonstrate that both currents are in charge of enhanced cell proliferation. 
 
Material and Methods 
 
Cell culture and proliferation studies 
Human colorectal carcinoma epithelial T84 cells (American Type Culture Collection, Rockville, 
Human colorectal carcinoma epithelial T84 cells (ATCC, Rockville, MD, USA) were grown in 
DMEM/Ham's F-12 medium (1:1) supplemented with 10% fetal bovine serum, 2 mM 
glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin (Invitrogen, Karlsruhe, 
Germany) at 5% CO2/37ºC. Cells were seeded on fibronectin (Invitrogen)/collagen (Cellon, 
Luxembourg) coated glass cover slips. Typically these cells grow slowly as polarized 
monolayers (T84-slow). Due to spontaneous transformation, a T84 cell line was selected which 
grew remarkably faster (T84-fast). For proliferation assays cells were plated at a density of 
2000 cells/0.35 cm2 and incubated 2 days later with either niflumic acid (0,01–100mM) or 
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astemizole (0,5–5000nM). Cell proliferation was assessed by 5-bromo-2´-deoxyuridine 
(BrdU) incorporation using an ELISA kit (Roche, Penzberg, Germany) and cell counting. The 
cell number was assessed after fixation in 3.7% formaldehyde / 0.5% Triton X-100 for 30 
minutes at room temperature and after staining with Mayer’s hemalaun (Merck, Darmstadt, 
Germany) for 5 minutes. Digitized microscopic images were taken (Fluovert FS, Leitz, 
Germany) and nuclei were counted using imaging software (TINA 2.09g). Toxicity of the 
blockers was assessed using Trypan Blue (Sigma). Each experiment was performed at least 
in triplicate. 
 
Cell cycle, FACS analysis, Caspase assay, RT-PCR 
Cells were synchronized into early G1 by 24h serum starvation. Incubation in thymidine (2 
mM), (Sigma) halted the cells at G1/S transition. 36h treatment with demecolcine (0.05 
µg/ml) (Sigma) synchronized into M phase. Synchronization was verified by FACS 
(COULTER EPICS® XL-MCL, Beckmann, Miami, USA) using propidium iodide staining of the 
DNA (Sigma). Apoptosis was analyzed after 8h and 24 h incubation with the protein kinase C 
inhibitor staurosporine (1 µM), (Sigma) and detection of cleaved caspase-3 in western blots 
using rabbit anti-human caspase-3 antibody (1:1000, Cell Signaling Technology, Inc., 
Danvers, USA). For RT-PCR total RNA was isolated using NucleoSpin RNA II columns 
(Macherey-Nagel, Düren, Germany). 1 µg total RNA was reverse transcribed for 1 h at 37˚C 
using random primer and RT (M-MLV Reverse Transcriptase, Promega, Mannheim, 
Germany). For PCR the following primers were used: hEag1 (KCNH1, NM_002238): 5´-
CGCATGAACTACCTGAAGACG-3´ (s), 5´-TCTGTGGATGGGGCGATGTTC-3´ (as), 560 bp. 
hBest1 (VMD2, NM_004183): 5´-CTGCTCTGCTACTACATCATC-3´ (s), 5´-
GTGTCCACACTGAGTACGC-3´ (as), 552 bp. The conditions were: 94˚C / 2 min, 35 cycles 
of 94˚C / 30 sec, 58°C / 30 sec and 72˚C / 1 min. PCR products were visualized by loading 
on 2% agarose gels and verified by sequencing. 
 
Down regulation of Best1 and Eag1 expression by RNAi 
Three different batches (A, B, C) of duplexes of 21-nucleotide RNAi with 3'-overhanging TT 
were purchased from Invitrogen (Karlsruhe, Germany). The sense strands of the RNAi used 
to silence the Best1 gene were 5´-AAUUCCUGUCGACAAUCCA-GUUGGU-3´(A), 5´-
AUCUCAUCCACA-GCCAACAGGGACA-3´(B), and 5´-UAAAUAAAGCGGAUGAUGUAG 
UAGC-3´(C). RNAi sequences for Eag1 are shown in (44). Fluorophore labeled RNAi and 
exposure to the transfection reagent lipofectamine 2000, (Invitrogen) served as controls. 
After 48 hrs cells were further processed in proliferation assays and for western blotting. 
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Detection of Eag1 and Best1 by Western blotting 
T84 cells were homogenized in lyses buffer (mmol/l: NaCl 150, Tris 50, DTT 100, 1% NP-40, 
and 1% protease inhibitor cocktail) (Sigma). Equal amounts of total protein (50 µg) were 
separated by 7% SDS-PAGE, transferred to Hybond-P (Amersham Biosiences, Freiburg, 
Germany) and incubated with either rabbit anti-hKv10.1 (Eag1) (Alomone labs, Jerusalem, 
Israel) or rabbit anti-hVMD-2 (Best1) (52) antibodies. Proteins were visualized using goat 
anti-rabbit IgG conjugated to horseradish peroxidase (Acris Antibodies, Hiddenhausen, 
Germany) and ECL (Amersham). Signals were detected by an Fluor-STM MultiImager (Bio-
Rad Laboratories, Hercules, USA). 
 
Measurement of the intracellular Ca2+ concentration and cell volume 
T84 cells were loaded with 2 µM Fura-2 AM (Molecular Probes, Eugene, USA) in Opti-MEM 
medium (GIBCO) with 2.5 mM probenecid (Sigma) for 1h at room temperature. Fluorescence 
was detected in cells perfused with ringer solution containing 2.5 mM probenecid (Sigma) at 
37°C, using an inverted microscope IMT-2 (Olympus, Nürnberg, Germany) and a high-speed 
polychromator system (VisiChrome, Puchheim, Germany). Fura-2 was excited at 340/380 
nm and emission was recorded between 470 and 550 nm using a CCD camera (CoolSnap 
HQ, Visitron). [Ca2+]i was calculated from the 340/380 nm fluorescence ratio (after 
background subtraction). The formula used to calculate [Ca2+]i was [Ca2+]i = Kd x (R-
Rmin)(Rmax-R) x (Sf2/Sb2) where R is the observed fluorescence ratio. The values Rmax, Rmin 
(maximum and minimum ratios) and the constant Sf2/Sb2 (fluorescence of free and Ca2+-
bound fura-2 at 380 nm) were calculated, using 2 µmol/l ionomycin (Calbiochem), 5 µmol/l 
nigericin, 10µmol/l monensin (Sigma) and 5 mmol/l EGTA to equilibrate intracellular and 
extra cellular Ca2+ in intact fura-2-loaded cells. The dissociation constant for the fura-2-Ca2+ 
complex was taken as 224 nmol/l. 
Cell volume was measured directly by Zeiss-Axiovert 200M/ApoTome using Axiovision 
software or was assessed by fluorescence measurements in calcein (2 µM; Molecular 
Probes, USA) loaded cells at an excitation of 500 nm and emission of 520-550 nm. The 
experiments were done in the presence of 2.5 mM probenecid. The control isotonic solution 
(290 mOsm) was prepared by adding 120 mM mannitol. The hypotonic (170 mOsm) and 
control isotonic solution contained 85 mM NaCl. 
 
Patch clamping 
Cell culture dishes were mounted on the stage of an inverted microscope (IM35, Zeiss, 
Germany), and perfused continuously (37°C) with Ringer solution. Patch-clamp experiments 
were performed in the fast and slow whole-cell configuration. Patch pipettes had an input 
resistance of 2–4 MΩ, when filled with a solution containing (mM) KCl 30, K-gluconate 95, 
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NaH2PO4 1.2, Na2HPO4 4.8, EGTA 1, Ca-gluconate 0.758, MgCl2 1.034, D-glucose 5, ATP 3. 
pH was adjusted to 7.2, the Ca2+ activity was 0.1 µM. The access conductance was 
monitored continuously and was 60–120 nS. Currents (voltage clamp) and voltages (current 
clamp) were recorded using an EPC7 amplifier (HEKA, Darmstadt, Germany), the LH1600 
interface and PULSE software (HEKA) as well as Chart software (AD-Instruments, 
Spechbach, Germany). In intervals membrane voltages (Vc) were clamped in steps of 10 mV 
from -50 to +50 mV relative to resting potential. The membrane conductance Gm was 
calculated from the measured current (I) and Vc values according to Ohm’s law. 
 
Materials and statistical analysis 
All compounds used were of highest available grade of purity. Astemizole, niflumic acid 
(NFA), DIDS, tetrapentylammonium (TPeA), carbachol, and ATP were all from SIGMA 
(Taufkirchen, Germany). Student’s t-test (for paired or unpaired samples as appropriate) and 
analysis of variance (ANOVA) was used for statistical analysis. P<0.05 was accepted as 
significant. 
 
Results 
 
Fast growing colonic carcinoma cells (T84-fast) express Eag1 and Best1 
T84 cells typically grow in slowly expanding patches (T84-slow), which form tight and polarized 
monolayers after 10 to 14 days, even when grown on impermeable supports (Fig. 2-1A, B). 
Apoptotic cells are regularly observed in the supernatant. At passage number 73, the cell line 
spontaneously changed its growth pattern, i.e. the cells grew remarkably faster (T84-fast) as 
singe single cells, non-polarized and above each other (Fig. 2-1A, B). No apoptotic cells 
were found in the supernatant. We examined apoptosis by analyzing uncleaved and cleaved 
caspase 3 by Western blotting and found small amounts of cleaved caspase 3 in T84-slow, 
but not in T84-fast cells after treatment with the PKC inhibitor staurosporin (1 µM) (Fig. 2-1C).  
 
RT-PCR analysis of the voltage gated K+ channel Eag1 and the putative Ca2+ activated Cl- 
channel Best1 suggested a higher number of transcripts for Eag1 and Best1 in T84-fast cells 
(Fig. 2-1D). Increased expression of Eag1 and Best1 was confirmed by Western blotting, 
which demonstrated much higher levels of Eag1 protein and Best1 protein in T84-fast cells 
(Fig. 2-1E). The membrane conductance properties were analyzed in T84-slow and T84-fast 
cells in whole cell patch clamp experiments and membrane voltages (Vm) were measured in 
the current clamp mode. T84-slow cells (n = 8) were more hyperpolarized (-51.7 ± 5.6 mV) 
and had a lower baseline conductance (3.8 ± 0.7 nS) than T84-fast cells (-36.6 ± 2.9 mV and 
23.8 ± 2.9 nS, n = 8). The increased baseline conductance and depolarized Vm of T84-fast 
cells was due to a higher activity of Cl- channels, since replacement of extra cellular Cl- by 
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gluconate (5Cl) shifted the I/V curve to more positive clamp voltages. This was not observed 
for T84-slow cells (Fig. 2-1F). 
 
 
 
Fig. 2-1 Slow and fast growing T84 cells 
A) Typical growth patterns of T84-slow cells as obtained from ATCC, and spontaneously 
transformed T84-fast cells. Bars indicate 50 µm. B) Proliferation curves for T84-slow and 
T84-fast cells, as obtained by cell counting (n = 4). C) Western blot for uncleaved and 
cleaved caspase-3 in T84-slow and T84-fast cells after 8 and 24 h incubation with 1 µM 
staurosporine (stauro). D) RT-PCR analysis of mRNA expression for Eag1 (560 bp) and 
Best1 (552 bp) in slow and fast growing T84 cells. +/- RT indicates presence or absence of 
reverse transcriptase. For PCR conditions c.f. Methods. E) Western blot analysis of the 
expression of Eag1 and Best1 in slow and fast growing T84 cells. Actin indicates equal 
loading of the gel. F) Whole cell currents measured in slow and fast growing T84 cells 
under control conditions (upper panels). Corresponding current/voltage relationships (n = 
8 for both cell types; lower panels). Replacement of extracellular Cl- by gluconate (5Cl) 
shifted the i/v curve to more depolarized clamp voltages only in fast growing T84 cells, 
indicating the presence of a baseline Cl- conductance. RT-PCR and Western blots were 
performed at least in triplicates. 
 
Eag1 controls proliferation of fast but not of slow growing T84 cells 
Eag1 has been demonstrated to support proliferation of several different cell types (44, 53). 
We therefore examined if high expression levels of Eag1 correlate with increased 
proliferation of T84-fast cells. To that end T84-slow and T84-fast cells were treated with three 
different batches (A-C) of siRNA for Eag1. Incubation of the cells with either fluorescence 
labeled scrambled oligos or lipid (transfection reagent) and non-treated cells served as 
controls. Measurement of BrdU incorporation clearly indicates inhibition of proliferation of T84-
fast cells after treatment with siRNA for Eag1 (Fig. 2-2A). siRNA treatment of T84-slow cells 
did not affect cell proliferation, suggesting a proliferative function of Eag1 only in T84-fast 
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cells. Notably, Eag1 expression was significantly upregulated by re-addition of 10% FCS in 
serum starved cells (data not shown). Using the inhibitor astemizole (5 µM), we examined 
the contribution of Eag1 to whole cell currents measured in T84-slow and T84-fast cells. 
Astemizole inhibited whole cell currents in both cell types, however, the effect was more 
pronounced in T84-fast cells and thus astemizole-sensitive whole cell currents were 
significantly larger in T84-fast cells (Fig. 2-2B,C). 
 
A previous report supplied evidence that hyperpolarizing Eag1 currents assist in the increase 
of intracellular Ca2+ ([Ca2+]i), when cells are stimulated with secretagogues (ATP, carbachol) 
or mitogens, and may thereby support proliferation (44). We compared increase in [Ca2+]i in 
Fura-2 loaded T84-slow and T84-fast cells upon stimulation with ATP (100 µM). ATP binds to 
purinergic P2Y2 receptors and thereby induces a peak and plateau [Ca2+]i increase in both 
cell lines (Fig. 2-2D). However, the peak [Ca2+]i increase was doubled in T84-fast when 
compared with T84-slow cells, which may indicate a role of Eag1 for Ca2+ signaling in T84-fast 
cells (Fig. 2-2D,E). 
 
 
 
Fig. 2-2 Eag1 supports proliferation of fast growing T84 cells 
A) Proliferation of slow and fast growing T84 cells as measured by BrdU incorporation. 
Cells were treated with three different batches (A-C) of siRNA for Eag1. Incubation of the 
cells with fluorescence labeled scrambled oligos (Oligos) or transfection reagent only 
(Lipid) and non-treated cells (Control) served as controls. Assays were performed at least 
in triplicates. * indicate significant inhibition of proliferation by RNAi in T84-fast cells 
(ANOVA). B) Whole cell currents in T84-slow and T84-fast cells and effect of the Eag1 
inhibitor astemizole (Aste; 5 µM). C) Summary of the calculated astemizole sensitive 
whole cell conductances (GAste) in T84-slow (n = 8) and T84-fast (n = 9) cells. GAste was 
significant in both cell lines and was enhanced in T84-fast cells (unpaired t-test). D) 
Increase of the intracellular Ca2+ concentration ([Ca2+]i) by stimulation with ATP (100 µM) 
in T84-slow and T84-fast cells. E) Summary of the ATP induced peak and plateau increase 
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in [Ca2+]i in slow (n = 59) and fast (n = 69) growing T84 cells. * indicates significant 
difference in peak [Ca2+]i increase in T84-fast cells. 
 
Eag1 activity in T84-fast cells is cell cycle dependent 
In other cell types Eag1-activity varies during the cell cycle (53). Therefore we examined cell 
cycle dependence of Eag1 in T84-fast cells. Cells were synchronized in early G1 (eG1), G1/S 
or M phase (c.f. methods), and synchronization was verified by FACS analysis (Fig. 2-3A). 
 
 
 
Fig. 2-3 Eag1 operates as a cell cycle regulated channel in fast growing T84 cells 
A) FACS analysis of fast growing T84 cells synchronized in early G1 (eG1), G1/S transition 
and M phase (c.f. Methods). Experiments were performed at least in triplicates. B) 
Astemizole sensitive whole cell conductances (GAste) measured in T84-fast cells 
synchronized in eG1 (n = 14), G1/S (n = 9) and M (n = 9) phase. GAste was significant 
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during all cell cycle phases but was enhanced during G1/S (ANOVA). C) Upper panel: 
Summary of the peak and plateau [Ca2+]i increase induced by CCH in T84-fast cells, 
synchronized into eG1 and effects of 0.5 µM astemizole (Aste, n = 73). Lower panel: 
Summary of the peak and plateau [Ca2+]i increase induced by CCH in T84-fast cells, 
synchronized into G1/S and effects of 0.5 µM astemizole (Aste, n = 64). The effect of 
astemizole was significant in all series (paired t-test) and was enhanced for plateau [Ca2+]i 
increase in G1/S when compared to eG1 (unpaired t-test). 
 
We found that astemizole sensitive whole cell currents were augmented in cells 
synchronized in G1/S, when compared to eG1 or M phase (Fig. 2-3B). T84 cells also express 
other voltage gated K+ channels such as Kv1.5 or Kv3.4, which are blocked by the inhibitor 
TPeA (44). However, in contrast to Eag1, TPeA sensitive whole cell currents were not cell 
cycle dependent (data not shown). We further compared the increase in [Ca2+]i in T84-fast 
cells synchronized in eG1 and G1/S phase. Both peak and plateau [Ca2+]i increase were 
significantly enhanced in G1/S-cells. Moreover, the Eag1-blocker astemizole inhibited peak 
and plateau [Ca2+]i increase in both cell cycle phases, but the effect of astemizole on plateau 
[Ca2+]i was augmented in the G1/S phase (Fig. 2-3C). These results supply evidence for cell 
cycle regulated Eag1-currents in T84-fast cells and cell cycle dependent effects of Eag1 on 
Ca2+ signaling. 
 
Best1 controls proliferation of fast but not of slow growing T84 cells 
Because T84-fast cells show much higher expression of Best1 when compared with T84-slow 
cells (Fig. 2-4A), we examined the effect of this putative Ca2+ activated Cl- channel on cell 
proliferation. T84-slow and T84-fast cells were treated with three different batches (A-C) of 
siRNA for Best1, which reduced Best1 levels in T84-fast cells. Expression levels in T84-slow 
cells were already very low (Fig. 2-4A,B). Incubation of the cells with either fluorescence 
labeled scrambled oligos or transfection reagent (lipid) and non-treated cells served as 
controls. Measurement of BrdU incorporation clearly indicates inhibition of proliferation of T84-
fast cells after treatment with siRNA for Best1 (Fig. 2-4C). No effects of siRNA were seen in 
T84-slow cells, suggesting a proliferative function of Best1 only in T84-fast cells.  
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Fig. 2-4 Best1 supports proliferation of fast growing T84 cells 
A) Western blot analysis of Best1 in T84-slow and T84-fast cells treated with three different 
batches (A-C) of siRNA for Best1. Incubation of the cells with fluorescence labeled 
scrambled oligos (Oligos) or non-treated cells (Control) served as controls. Actin indicates 
equal loading of the gels. B) Densitometric analysis of Best1 expression and ratio 
between Best1 and actin expression. C) Proliferation of slow and fast growing T84 cells as 
measured by BrdU incorporation. Assays were performed at least in triplicates. * indicate 
significant inhibition of proliferation by RNAi in T84-fast cells (ANOVA). 
 
In whole cell patch clamp experiments, the high baseline conductance found in T84-fast cells 
could be partially inhibited by the blockers of Ca2+ activated Cl- channels, NFA and DIDS 
(both 100 µM). Both inhibitors had no effect in T84-slow cells (Fig. 2-5A). Stimulation with 
ATP (100 µM) to increase intracellular Ca2+ (Fig. 2-2D), activated a whole cell current in T84-
slow but not in T84-fast cells (Fig. 2-5B). In T84-slow cells, ATP activated primarily a K+ 
conductance, as indicated by the hyperpolarizing effect of ATP on the membrane voltage 
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(Fig. 2-5C). Little effects of ATP were seen in T84-fast cells. Correspondingly, replacement of 
extra cellular Cl- by impermeable gluconate (5Cl) showed no effects in T84-slow cells, but 
reduced the baseline conductance in T84-fast cells (Fig. 2-5D). Taken together, these results 
suggest active Best1 Cl- channels in non-stimulated T84-fast cells, which cause enhanced 
proliferation.  
 
 
 
Fig. 2-5 T84-fast but not T84-slow cells have a Cl- conductance. 
A) Summaries for the baseline whole cell conductances (G) and effects of the inhibitors of 
Ca2+-activated Cl- channels, niflumic acid (NFA; 10 µM) and DIDS (100 µM) in slow and 
fast growing T84 cells (n = 8 – 11). * indicate significant effects of NFA and DIDS (paired t-
test). B) Whole cell currents measured in T84-slow and T84-fast cells. Stimulation of the 
cells with ATP (100 µM) activated a whole cell conductance only in T84-slow but not in T84-
fast cells. C) Summaries for the whole cell conductances (upper panels) and membrane 
voltages (lower panels) measured in T84-slow (n = 13) and T84-fast (n = 14) cells, and 
effects of ATP (100 µM). * indicate significant effects on whole cell conductance and 
membrane voltages (paired t-test). D) Summaries for the whole cell conductances 
measured in T84-slow (n = 9) and T84-fast (n = 8) cells, and effect of replacement of 
extracellular Cl- by gluconate (5Cl) and ATP (100 µM).  * indicate significant activation of 
conductance by ATP in T84-slow cells and significant inhibition by 5Cl (paired t-test). 
 
Increased proliferation and Cl- conductance in Best1-transfected T84-slow cells 
To further demonstrate that Best1 contributes to proliferation of T84 cells, we expressed 
human Best1 in T84-slow cells. As shown in Fig. 2-6A, transfection of 100 ng of exogenous 
Best1 increased Best1 expression in T84-slow cells almost to the level found in T84-slow cells. 
No change was seen in mock-transfected cells. Notably, over expression of Best1 changed 
the growth pattern of T84-slow cells towards that found for T84-fast cells (Fig. 2-6B). Moreover, 
after expression of Best1, a DIDS-sensitive whole cell current appeared in T84-slow cells, 
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which was not found in mock-transfected or parental cells (Fig. 2-6C). Measurement of the 
BrdU-incorporation indicated a significant increase in proliferation of Best1-transfected T84-
slow cells, which was not observed for mock-transfected cells (Fig. 2-6D). In summary, both 
Eag1 K+ channels and Best1 Cl- channels are upregulated in spontaneously transformed T84 
cells, where they augment proliferation.  
 
 
 
Fig. 2-6 Expression of Best1 in T84-slow cells enhances Cl- currents and 
proliferation 
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A) Western blot analysis of human Best1 expression in T84-slow cells after transfection of 
50 or 100 ng of Best1 cDNA, or mock (50 and 100 ng) transfection, and comparison with 
the level of Best1 expression in T84-fast cells and non-transfected T84-slow cells. Actin 
indicates equal loading of the gel. B) Growth pattern of mock transfected (- Best1) and 
Best1 transfected (+Best1) T84-slow cells. Bars indicate 50 µm. C) Upper panel: Whole 
cell currents measured in mock-transfected and Best1-transfected T84-slow cells and 
effect of DIDS (100 µM). Lower panel: Summaries of the whole cell conductances and 
effects of DIDS on mock transfected (n = 7) and Best1 transfected (n = 7) T84-fast cells. * 
indicates significant inhibition of whole cell conductance by DIDS (paired t-test). D) 
Proliferation of mock transfected (50 and 100 ng) and Best1 transfected (50 and 100 ng) 
cells. Non-transfected cells (Control) and cells exposed the transfection reagent only 
(Lipids) served as controls. * indicate significant increase in proliferation (ANOVA). 
 
Eag1 and Best1 support intracellular Ca2+ signaling and volume regulation, 
respectively 
Eag1 K+ channels (and to some degree Best1) have a clear impact on intracellular Ca2+ 
signaling. This was demonstrated by stimulation with ATP (100 µM), which increased 
intracellular peak (ER- Ca2+ release) and plateau (Ca2+ - influx through SOC) in T84-fast cells. 
Treatment with siRNA for Eag1 significantly reduced peak and plateau Ca2+ increase (Fig. 2-
7A). Volume measurements indicate stronger cell swelling and potent regulatory volume 
decrease (RVD) in T84-fast, when compared to T84-slow cells, as identified by direct volume 
measurements and indirect measurements of calcein fluorescence (Fig. 2-7B-E). T84-fast 
cells treated with siRNA-Best1 show reduced RVD (Fig. 2-7B). As both intracellular Ca2+ and 
cell volume control is essential for the mitotic cell cycle, these results may provide a 
mechanism for the proliferative role of Eag1 and Best1. 
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Fig. 2-7 Eag1 and Best1 support intracellular Ca2+ signaling and volume regulation 
A) Summary of intracellular peak (left) and plateau (right) Ca2+ increase in T84-fast cells, 
upon stimulation with ATP (100 µM). Cells were treated with scrambled siRNA or siEag1 
and siBest1, respectively (n = 24 – 57). B) Hypotonic (170 mosmol) cell swelling assessed 
by volume measurement in T84-slow and T84-fast cells (upper trace) and T84-fast cells 
treated with siRNA-Best1 or control transfection (GFP) (n = 5 each time point). C) Change 
in calcein fluorescence due to hypotonic cell swelling. D,E) Summaries for maximal 
change in fluorescence intensity and slope of recovery (from swelling) of T84-slow and T84-
fast cells (n = 12). * indicate significant difference (paired t-test). 
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Discussion 
 
Transformation of colonic epithelial cells increases proliferation and ion 
conductances 
T84 colonic carcinoma cells are well established (7, 54). They grow slowly in patches and 
form tight and polarized monolayers, when cultured on permeable supports. T84 cells were 
used for numerous electrophysiological studies and resemble a model for electrolyte 
transport in the colonic epithelium (54). They show many aspects of native epithelial cells 
such as a relatively hyperpolarized membrane voltage and Cl- secretion by cAMP-dependent 
cystic fibrosis transmembrane conductance regulator (CFTR) channels. When stimulated by 
secretagogues, which increase the intracellular Ca2+ concentration such as ATP or 
carbachol, predominantly K+ channels are activated, hyperpolarizing the membrane voltage. 
This is comparable to colonic crypt cells, which also activate Ca2+ activated K+ channels upon 
stimulation of basolateral muscarinic M3 and apical purinergic P2Y2 receptors (7, 55). In 
contrast, T84 cells that had undergone spontaneous transformation were remarkably different. 
They proliferated much faster, showed typical features of malignancy and had different 
membrane conductances.  
 
A change in membrane ion conductance has also been reported for spontaneously 
transformed Madin-Darby canine kidney (MDCK) cells. These fast growing MDCK-F cells 
express Ca2+ activated K+ channels that largely enhance cell migration (56). The fast growing 
T84 cells described in the present study, showed a strong increase in the expression of the 
Best1 Cl- channel, along with Eag1 potassium channels. Notably, the Cl- channels were 
already active in non-stimulated cells, i.e. without purinergic stimulation. Additional increase 
of intracellular Ca2+ by ATP or carbachol did not further increase Cl- conductance. A similar 
result was obtained when Best1 was over expressed in T84-slow cells, and has also been 
observed when Best1 was expressed in Hek293 cells (45). It suggests that additional 
components may be required for Ca2+ -regulation of Best1 currents, which may not be 
present in cancer cells. The presence of these DIDS-sensitive Cl- currents along with 
astemizole inhibited Eag1 K+ currents clearly augmented cell proliferation 
 
Ion channels induce malignancy and metastatic cell growth 
Clonal selection of fast proliferating T84 cells (T84SF) has previously been reported (57). 
These cells demonstrate invasive and metastatic cell growth, when transferred into nude 
mice. Basal tyrosine phosphorylation and expression of src kinase were enhanced in these 
T84SF cells (57). Along this line, the src-inhibitor PP2 reduced cell growth, invasion and cell 
adhesion of T84SF cells (58). In Jurkat T lymphocytes, src kinase controls voltage-dependent 
Kv1.3 K+ channels, which also affect cell proliferation (59). Src kinase may also be up 
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regulated in fast growing T84 cells and may be responsible for changes in membrane 
conductance. It will be interesting to examine in subsequent studies the impact of Eag1 and 
Best1 on cell migration and tissue invasion, since we previously found that genomic 
amplification of Eag1 in human colorectal carcinoma is an independent marker of adverse 
prognosis (60). 
 
How do ion channels determine malignancy? 
K+ and Cl- channels are essential for cell migration and metastasis of cancer (61). It has been 
shown that enhanced intracellular Ca2+ activates Kv channels during intestinal wound healing 
(62). Cell migration and formation of tumor metastasis is due to fluctuations in the activity of 
membrane transporters and ion channels, since they cause localized cell swelling and 
shrinkage (61). These changes in cell volume appear to be a prerequisite for cell migration 
and malignant invasion. There are only a few studies investigating the role of Cl- channels in 
cell migration. Cl- channels are probably necessary for cell movement, since K+ transport 
needs to be accompanied by a counterion (56). Notably, bestrophin has been shown to 
operate as a volume sensitive Cl- channel (63). 
 
A novel function of bestrophin for cell proliferation? 
Cl- currents induced by expression of bestrophins share many of the properties attributed to 
Ca2+ activated Cl- channels, such as an anion selectivity of I- > Cl- and inhibition by NFA and 
DIDS (48-50, 52). There is, however, an ongoing controversy whether bestrophins are 
actually channel forming proteins or rather regulators of ion channels. Moreover, other 
proteins have also been proposed as molecular candidates for the Ca2+ activated Cl- channel 
(reviewed in (45). The present results would support the role of Best1 as a Cl- channel. As 
known from previous studies, Ca2+ and volume regulated Cl- channels support cell 
proliferation (6). Thus bestrophins may provide the molecular basis for an understanding of 
the role of these channels in cell proliferation. 
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Chapter 3 
 
 
Voltage gated K+ channels support proliferation of colonic carcinoma cells 
 
Abstract 
 
Plasma membrane potassium (K+) channels are required for cell proliferation. Evidence is 
growing that K+ channels play a central role in the development and growth of human cancer. 
Here we examine the contribution and the mechanism by which K+ channels control 
proliferation of T84 human colonic carcinoma cells. Numerous K+ channels are expressed in 
T84 cells, but only voltage gated K+ (Kv) channels influenced proliferation. A number Kv 
channel inhibitors reduced DNA- synthesis and cell number, without exerting apoptotic or 
toxic effects. Expression of several Kv channels such as Eag1, Kv 3.4 and Kv 1.5 was 
detected in patch clamp experiments and in fluorescence based assays, using a voltage 
sensitive dye. The contribution of Eag1 channels to proliferation was confirmed by siRNA, 
which abolished Eag1 activity and inhibited cell growth. Inhibition of Kv channels did not 
interfere with the ability of T84 cells to regulate their cell volume, but restricted intracellular pH 
regulation. In addition, inhibitors of Kv channels as well as siRNA for Eag1 attenuated 
intracellular Ca2+ signaling. The data suggest that Kv channels control proliferation of colonic 
cancer cells by affecting intracellular pH and Ca2+ signaling. 
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Introduction 
 
Apart from their specific epithelial transport function, membrane ion channels are essential 
for maintaining cellular homeostasis and signaling. Thus they contribute to the control of 
essential parameters such as cell volume, intracellular pH and intracellular Ca2+ 
concentration. K+ selective ion channels form the largest ion channel protein family, which 
may be subdivided into voltage gated, Ca2+ dependent, 2-pore domain, and inward rectifier 
K+ channels. It has recently been suggested that in addition to the physiological parameters 
controlled by K+ channels, they also affect mitotic cell cycling, proliferation and development 
of cancer. A role of K+ channels for proliferation and tumor cell growth has been 
demonstrated for a number of carcinoma, like those of prostate, colon, lung, breast and 
others (14). K+ channels of different subfamilies have been correlated with tumor 
proliferation, including Ca2+ activated K+ channels, Shaker-type voltage-gated K+ channels, 
the ether-á-go-go (Eag1) family of voltage gated K+ channels and the 2P-domain K+ channels 
(14, 15, 41, 64). It is not known currently, why different types of K+ channels induce 
proliferation in the different cancer models. Most of the previous studies describe expression 
of a particular type of K+ channel in a cancer cell line and correlate expression and functional 
activity of the channel with proliferation. However, mammalian cells always express a whole 
array of various types of K+ channels, and it is not clear to what degree these individual K+ 
channels contribute to proliferation, or if there is a specific association between particular K+ 
channel subtypes and proliferation. Moreover the mechanisms by which these K+ channels 
facilitate cell proliferation remain obscure. 
Colonic carcinomas belong to the most frequent cancers in human. A previous study found a 
correlation between the activity of voltage gated K+ channels and proliferation and metastasis 
of a colonic cancer cell line and native colonic cancers, respectively (16, 65). Interestingly 
Ca2+ influx into colonic cancer cells was affected by voltage gated K+ channels in one study 
(65). Identification of K+ channels which are relevant for the growth of colonic carcinomas 
may provide novel therapeutic targets (66, 67). Moreover, K+ channels abnormally expressed 
in colonic cancer cells could be potentially useful as markers for malign transformation. In the 
present study, we therefore screened T84 colonic carcinoma cells for expression of a broad 
spectrum of K+ channels. We then tried to identify the K+ channels that have an impact on 
proliferation of these cells. Using a variety of K+ channel blockers and siRNA, we found that 
voltage gated K+ channels take part in controlling cell proliferation, while other K+ channel 
subtypes do not. A further aim of this study was to uncover how these channels affect 
proliferation. The data suggest that voltage gated K+ channels control basic cellular 
properties like intracellular Ca2+, elicited by agonist stimulation of the cells, and regulation of 
the intracellular pH. Both effects are likely to be due to the hyperpolarizing effect of Kv 
channels on the membrane voltage. 
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Material and Methods 
 
Cell culture and proliferation studies 
Human colorectal carcinoma epithelial T84 cells (American Type Culture Collection, Rockville, 
MD, USA), were grown in DMEM/Ham's F-12 medium (1:1), supplemented with 10% fetal 
bovine serum (FBS), 2 mM glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin 
(Pen/Strep) (GIBCO, Germany) in a 5% CO2 atmosphere at 37ºC. Cells were seeded on 
bovine plasma fibronectin (Invitrogen, Germany) and bovine dermal collagen (Cellon, 
Luxembourg) coated plastic dishes or glass cover slips. For proliferation assays, T84 cells 
were plated at a density of 2000 cells/0.35 cm2 on coated 96 well plates (Sarstedt, Nürnberg, 
Germany). After 2 days, cells were incubated with inhibitors of potassium channels dissolved 
in serum reduced Opti-MEM 1 medium (GIBCO, Germany). After additional 2 days, cell 
proliferation was assessed by 5-bromo-2´-deoxyuridine (BrdU) incorporation and cell 
counting. BrdU incorporation was determined using an immunoassay cell proliferation ELISA 
kit (Roche, Germany), according to the manufacturer’s protocol. For cell counting, cells were 
fixed with 3.7% formaldehyde and 0.5% Triton X-100 in ringer solution (mmol/l: NaCl 145; 
KH2PO4 0,4; K2HPO4 1,6; Glucose 5; MgCl2 1; Ca2+-Gluconat 1,3, pH 7.4) for 30 min and 
stained with Mayers Hemalaun (Merck, Darmstadt, Germany). Digital images were obtained 
and nuclei were counted using imaging software. Toxicity of the blockers was assessed by 
counting non-stained dead cells in the supernatants (Trypan Blue). Each experiment was 
performed in triplicate. 
 
Expression of potassium channels in T84 cells and real time PCR analysis 
Total RNA was isolated from T84 cells using NucleoSpin RNA II columns (Macherey-Nagel, 
Germany). 1 µg total RNA was reverse transcribed for 1 h at 37˚C using random primer and 
RT (M-MLV Reverse Transcriptase, Promega, Germany). RT-PCR was used to detect 
expression of the mRNAs for potassium channels. The oligonucleotide primers were 
designed for the mRNA of each gene product (name, gene, accession number: sense and 
antisense primer, size of PCR product): Kv1.3, KCNA3, NM_002232: 5´-
GCCATCCTCTACTACTATCAG-3´, 5´-CCACAATGTCGATCAGGTTC-3´, 532 bp; Kv1.5, 
KCNA5, NM_002234: 5´-CTACTTCGACCCCCTGAG-3´, 5´- 
GCTCGAAGGTGAACCAGATG-3´, 555 bp; KvLQT, KCNQ1, NM_000218: 5´- 
CCACGGGGACTCTCTTCTG-3´, 5´- GGCACCTTGTCCCCATAG-3´, 504 bp; Kv3.3 / Kv3.4, 
KCNC3/KCNC4, NM_004977: 5´- GACGTGCTGGGCTTCCTG-3´, 5´- 
GCTTCTGCTTGGCCATGG-3´, 442 bp; Kv4.1 , KCND1, NM_004979: 5´- 
GGAAGAATACGCTGGACCG-3´, 5´- GCGGCATGGGATGGTCTC-3´, 472 bp; Kv5.1, 
KCNF1, NM_002236: 5´- GAGTCGTCGTGCCCGGC-3´, 5´- GTCTCTGGATGGCTCTGCTC-
3´, 530bp; Kv9.3 , KCNS3, NM_002252: 5´- GTGCAGCCTGATCTTCCTC-3´, 5´- 
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GTGTCAAACTTCTCCAGCTC-3´, 540 bp; Eag1, KCNH1, NM 002238: 5´- 
GCATGAACTACCTGAAGACG-3´, 5´- CTTCTCAATGTCTGTGGATGG-3´, 488 bp; Erg1, 
KCNH2, NM 000238: 5´- CAATGCCAACGAGGAGGTG -3´, 5´- GGAGAGACGTTGCCGAAG 
-3, 468 bp; Elk1, KCNH8, NM_144633: 5´- GCCCGAACTGAAGTCATGC-3´, 5´- 
CAAAATAAGCCAGTCCCAGC-3´, 522 bp; Kir6.1, KCNJ8, NM_004982: 5´- 
GTTTGGAGTCCACTGTGTGTG-3´, 5´- CAGAATAACTATGACCTCCAAG-3´, 548 bp; 
TWIK1, KCNK1, NM_002245: 5´- GCTTCGGCTTCCTGGTGC-3´, 5´- 
GACAAACCCAAGGAGCACG-3´, 505 bp; TASK2 , KCNK5, NM_009740: 5´- 
GGCCATCACAGGGAACCAG-3´, 5´- GCCAGGCCAGCCCCAAG-3´, 496 bp; TWIK2, 
KCNK6, NM_004823: 5´- GATCTTTGCCCACCTCGAG-3´, 5´- 
GATGCTGGGAAACAAAGGAG-3´, 520 bp; BKCa channel ß-subunit, KCNMA1, NM_002247: 
5´- GTGGATGAAAAAGAGGAGGC-3´, 5´- CAAATGGATGAACCCGGCTG -3´, 528 bp; BKCa 
channel ß-subunit, KCNMB3, NM_014407:  5´- CGACCTGCACTGCCATCC-3´, 5´- 
GGGCACCACCTAGCAGAG-3´, 398 bp; BKCa channel ß-subunit, KCNMB4, NM_014505: 5´- 
CCAGGTCTACGTGAACAAC-3´, 5´- CTGTTGCCACTGAGGGATG-3´, 520 bp; SK4 , 
KCNN4, NM_002250: 5´- GATTTAGGGGCGCCGCTGAC-3´, 5´- 
CTTGCCCCACATGGTGCCC-3´, 520 bp. The PCR reactions were performed at 94˚C for 2 
min, 35 cycles at 94˚C for 30 s, annealing temperature 60°C for 30 s and 72˚C for 1 min. 
PCR products were visualized by loading on agarose gels and were verified by sequencing. 
 
Real time PCR was performed in a Light Cycler (Roche, Germany), using the Quanti Tect 
SYBR Green PCR Kit (Quiagen, Germany). Each reaction contained 2 µl Master Mix 
(including Taq polymerase, dNTPs, SYBR Green buffer), 1 pM of each primer (Eag1: 5´- 
GGAGTTCCAGACGGTGCAC-3´, 5´- CCTCATCATCTTGGATCACC-3´, 116 bp; β-actin , 
ACTB, NM 001101: 5´- CAACGGCTCCGGCATGTG-3´, 5´- CTTGCTCTGGGCCTCGTC-3´, 
151 bp), 2.5 mM MgCl2 and 2 µl cDNA. After 10 min at 94°C for activation of Taq 
polymerase, cDNA was amplified by 15 s at 94°C, 10 s at 60°C, and 20 s at 72°C, for 50 
cycles. The amplification was followed by a melting curve analysis to control of the PCR 
products. As negative controls, water instead of cDNA was run with every PCR experiment. 
To verify accuracy of the amplification, PCR products were further analyzed on ethidium 
bromide stained 2% agarose gels. Analysis of the data was performed using Light Cycler 
software 3.5.3. Standard curves for Eag1 channel mRNA and β-actin mRNA were produced 
by using cDNA of 16HBE cells at different dilutions. The ratio of the amount of Eag1 to β-
actin mRNA was calculated for each sample. 
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Downregulation of Eag1 expression by small interfering RNA 
Duplexes of 21-nucleotide siRNA with 3'-overhanging TT were designed according to Ahn et 
al 2003 (68) and synthesized by IBA (Göttingen, Germany). The sense strand of the siRNA 
used to silence the Eag1 gene was 5´- GACACGAUUGAA AAAGUGCTT-3´, corresponding 
to positions 268-286 of the Eag1 mRNA, relative to the start codon. The sense strand of the 
siRNA used to silence the potassium channel SK4 gene was 5´- GCGCUU 
GCUGGAGCAGGAGTT-3´, corresponding to positions 48-66 of the SK4 mRNA relative to 
the start codon. A control siRNA oligonucleotide, Lmo2, designed to silence the LIM domain 
only 2 T-cell oncogene (Mus musculus), has no target gene in T84 cells and was used as a 
negative control for transfection. It had the sequence 5´- GCC AUC GAC CAG UAC UGG 
CTT-3´ (positions 133-151 relative to the start codon) of the Lmo2 gene. Transfection of T84 
cells was carried out in Opti-MEM 1, one day after seeding using Oligofectamine (Invitrogen, 
Karlsruhe, Germany). After a 48 h rest, T84 cells were used for proliferation assays, patch 
clamp, real time PCR and western blot. 
 
Detection of Eag1 protein by Western blot 
Lysates of T84 cells were resolved by 7% SDS-PAGE, transferred to Hybond-P (Amersham 
Biosiences, Germany) and incubated with mouse anti-Kv10.1 (Eag1) antibodies (alomone 
labs, Jerusalem, Israel). Proteins were visualized using a goat anti-mouse IgG conjugated to 
horseradish peroxidase (Acris Antibodies, Germany) and ECL Advance Detection Kit 
(Amersham Biosiences, Germany). 
 
Measurement of the intracellular Ca2+ concentration, pH, cell volume and membrane 
potential 
T84 cells were loaded with 2 µM Fura-2 AM (Molecular Probes, USA) in Opti-MEM 1 medium 
with 2.5 mM probenecid (Sigma, Germany) for 1 h at room temperature. For fluorescence 
measurements of the intracellular Ca2+ concentration [Ca2+]i, cells were perfused with ringer 
solution containing 2.5 mM probenecide (Sigma, Deisenhofen, Germany) at 37°C. 
Fluorescence was measured continuously using an inverted microscope IMT-2 (Olympus, 
Nürnberg, Germany) and a high speed polychromator system (VisiChrome, Visitron 
Systems, Germany). Fura-2 was excited at 340/380 nm and emission were recorded 
between 470 and 550 nm using a CCD camera (CoolSnap HQ, Visitron Systems, Puchheim, 
Germany). [Ca2+]i was calculated from the ratio of 340/380 nm fluorescence values (after 
subtraction of background fluorescence). The formula used for calculation of [Ca2+]i was 
[Ca2+]i = Kd x (R-Rmin)(Rmax-R) x (Sf2/Sb2) where R is the observed fluorescence ratio. The 
values Rmax, Rmin (maximum and minimum ratios) and the constant Sf2/Sb2 (fluorescence of 
free and Ca2+-bound fura-2 at 380 nm) were calculated using 2 µmol/l ionomycin (free acid, 
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Calbiochem, Merck Biosciences, Bad Soden, Germany), 5 µmol/l nigericin (Sigma, 
Germany), 10µmol/l monensin (Sigma, Deisenhofen, Germany) and 5 mmol/l EGTA to 
equilibrate intracellular and extracellular Ca2+ in intact fura-2-loaded cells. The dissociation 
constant for the fura-2-Ca2+ complex was taken as 224 nmol/l. 
 
For assessment of intracellular pH, cells were incubated in standard bath solution (mM: 145 
NaCl, 0.4 KH2PO4, 1.6 K2HPO4, 5 glucose, 1 MgCl2, 1.3 Ca-gluconate, pH 7.4) containing 8 
µM BCECF-AM and 0.05% Pluronic for 30 - 60 min at room temperature (RT). For cell 
volume measurements M1 cells were loaded with 2.5 µM calcein-AM and 0.025% Pluronic in 
standard bath solution for 30 – 60 min at RT. Excitation wavelengths of 488/440 and 500 nm 
were used for BCECF and calcein loaded cells, respectively. Emission wavelengths were 
>520 nm for BCECF fluorescence and 520-550 nm for calcein fluorescence. We screened for 
the effect of K+ channel blockers on the membrane voltage, using the voltage sensitive dye 
FMP (69). Cells were incubated with FMP (FLIPR Membrane Potenial Assay Kit, Molecular 
Devices, Ismaning, Germany) in ringer solution at room temperature. FMP was exited with 
485 nm and emission was detected between 515 and 560 nm. All experiments were 
controlled and analyzed using the software package Meta-Fluor (Universal imaging, USA). 
All optical filters and dichroic mirrors were from AHF (Tübingen, Germany). 
 
Patch clamp 
Cell culture dishes were mounted on the stage of an inverted microscope (IM35, Zeiss) and 
kept at 37 °C. The bath was perfused continuously with Ringer solution at about 10 ml/min. 
Patch-clamp experiments were performed in the fast whole-cell configuration. Patch pipettes 
had an input resistance of 2–4 MΩ, when filled with a solution containing (mM) KCl 30, K-
gluconate 95, NaH2PO4 1.2, Na2HPO4 4.8, EGTA 1, Ca-gluconate 0.758, MgCl2 1.034, D-
glucose 5, ATP 3. pH was adjusted to 7.2, the Ca2+ activity was 0.1 µM. The access 
resistance was measured continuously during the recordings and was 8.3 – 14.2 MΩ. 
Currents (voltage clamp) and voltages (current clamp) were recorded using a patch-clamp 
amplifier (EPC 7, List Medical Electronics, Germany), the LH1600 interface and PULSE 
(HEKA, Germany) and Chart (AD-Instruments, Germany) software. In regular intervals, 
membrane voltages (Vm) were clamped in steps of 10 mV from -50 to +50 mV relative to 
resting potentials. The membrane conductance Gm was calculated from the measured 
current (I) and Vm values, according to Ohm’s law. 
 
Materials and statistical analysis 
All compounds used were of highest available grade of purity. 4-AP, TPeA, astemizole, 
calciseptine, EIPA, carbachol, quinidine, and terfenadine were all from Sigma (Deisenhofen, 
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Germany). BDS-I, charybdotoxin, and iberiotoxin were from Alamone labs (Jerusalem, 
Israel). Clotrimazole was from Calbiochem (Merck Biosciences, Bad Soden, Germany). 
Scyllatoxin was from Latoxan (Valence, France). TRAM-34 was a generous gift by Dr. H. 
Wulff (Department of Medical Pharmacology and Toxicology, University of California Davis, 
San Francisco, USA). 293B, AVE0118 and AVE1231 were gifts from Aventis Pharma 
(Frankfurt, Germany). All other chemicals were obtained from Merck (Darmstadt, Germany). 
The acetomethyl ester (2´,7´)-bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF-AM), 
calcein (calcein-AM), Fura2-AM and Pluronic were all from Molecular Probes (U.S.A.).  
Student’s t-test (for paired or unpaired samples as appropriate) and analysis of variance 
(ANOVA) was used for statistical analysis. P<0.05 was accepted as significant. 
 
Results 
 
Expression of cancer related K+ channels in T84 colonic carcinoma cells 
We broadly screened T84 cells for expression of K+ channels, based on previous reports 
indicating a role of K+ channels for proliferation of cancer cells (database SAGEmap of the 
Cancer Genome Anatomy Project, http://cgap.nci.nih.gov, (70) and recent publications). 
 
 
 
Fig. 3-1 Expression of K+ channels in T84 cells 
Expression of A) voltage gated (Kv3.3/3.4, Kv4.1, Kv5.1, Elk1, KvLQT1, Eag1, Kv9.3), B) 
inward rectifier (Kir6.1), two pore domain (TWIK1, TASK2, TWIK2), and C) large (BKCaβ3, 
BKCaβ4) and small (SK4) conductance Ca2+- activated K+ channels, after reverse 
transcription (RT). 
 
RT-PCR detected transcripts of a number of voltage-gated (Kv) K+ channels (Fig. 3-1A). 
Moreover, the ATP sensitive K+ channels Kir6.1 and the two-pore (2P)-domain K+ channels 
TWIK1, TWIK2 and TASK2 are expressed in T84 cells (Fig. 3-1B). Although, transcripts of the 
α-subunit of the large conductance Ca2+ sensitive (BK) channel could not be detected, the 
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two β-subunits β3 and β4 are expressed in these cells, along with intermediate conductance 
Ca2+ activated SK4 K+ channels (Fig. 3-1C). Taken together, several K+ channels are 
expressed in T84 colonic carcinoma cells, which may potentials support cell proliferation. 
 
Inhibition of T84 cell proliferation by blockage of Kv channels 
In order to identify K+ channels which affect cell proliferation, we used a variety of inhibitors 
(Table 3-1, Fig.3-2 and 3-3). Cell proliferation was assessed independently, by quantifying 
DNA replication (BrdU incorporation) and by cell counting. Potential toxicity of the K+ channel 
blockers was assessed by Trypan blue staining. At the concentrations used in this study, the 
channel inhibitors caused no toxic effects on T84 cells. 
Concentration dependent inhibition of cell proliferation was found for the non-selective Kv 
channel blockers TPeA and quinidine (71, 72), for the toxin inhibitor BDS-1, which blocks 
Kv3.4 channels (73), and for the Eag1 blocker terfenadine (74) (Fig. 3-2A-D). Other Kv 
inhibitors such as 4-AP (5 µM - 2mM), AVE0118 or AVE1231 (0.5 nM - 50 µM) and the 
KvLQT blocker 293B (1 nM - 10µM) also inhibited cell proliferation, albeit at higher 
concentrations (Table 2-1). Inhibitors of Ca2+ activated K+ channels, such as charybdotoxin, 
clotrimazole, iberiotoxin, scyllatoxin and TRAM-34 did not affect proliferation (Table 2-1). 
Thus, Ca2+ activated K+ channels do not seem to support proliferation. Surprisingly, activation 
of SK4 channels by riluzole (75) enhanced proliferation (Fig. 3-2E). These experiments 
suggest that only endogenous Kv channel activity supports proliferation of T84 colonic 
carcinoma cells, however, when up-regulated other K+ channels such as intermediate 
conductance SK4 channels may also enhance proliferation. Endogenous Kv channels not 
only support proliferation of T84 cells, but also that of other colonic cell lines, like HT29. 
Proliferation of HT29 cells was inhibited between 60 – 80% (n = 4) by 4-AP and astemizole. 
Moreover, Kv channels have been identified recently in human and murine colonic cancers 
(76). 
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Table 3-1 Inhibition of T84 cell proliferation by K+ channel blocker. 
Asterisks indicate significant difference when compared to control (ANOVA). Experiments 
were carried out in triplicates and numbers of different experiments are given in 
parentheses. 
 
inhibitor blocked channels concentration BrdU incorporation (% of control) 
cell number 
(% of control) 
 
293B 
 
 
 
 
 
4-AP 
 
 
 
 
 
astemizole 
 
 
 
 
 
AVE 0118 
 
 
 
 
 
AVE 1231 
 
 
 
 
 
charybdotoxin 
 
 
 
 
 
clotrimazole 
 
 
 
 
 
iberiotoxin 
 
 
 
 
scyllatoxin 
 
 
 
 
 
TRAM-34 
 
 
 
 
KvLQT 
 
 
 
 
 
Kv channels 
 
 
 
 
 
Eag1, Elk, Erg 
 
 
 
 
 
Kv1.5, 4.3, 2.1, 3.1 
 
 
 
 
 
Kv1.5, 4.3, 2.1, 3.1 
 
 
 
 
 
BKCa, SK4, Kv1.3 
 
 
 
 
 
SK4 
 
 
 
 
 
BKCa 
 
 
 
 
SK-family 
 
 
 
 
 
SK4 
 
 
 
 
10µM 
1µM 
0.1µM 
0.01µM 
0.001µM 
 
2mM 
1mM 
0.5mM 
0.05mM 
0.005mM 
 
5µM 
0.5µM 
0.05µM 
0.005µM 
0.5nM 
 
50µM 
5µM 
0.5µM 
0.05µM 
0.005µM 
 
50µM 
5µM 
0.5µM 
0.05µM 
0.005µM 
 
100nM 
10nM 
1nM 
0.1nM 
0.01nM 
 
1µM 
0.1µM 
0.01µM 
0.001µM 
10nM 
 
1nM 
0.1nM 
0.01nM 
0.001nM 
 
10nM 
1nM 
0.1nM 
0.01nM 
0.001nM 
 
100nM 
10nM 
1nM 
0.1nM 
 
 
79.0 ± 4.9 (3)* 
79.3 ± 1.4 (3)* 
80.7 ± 2.5 (3)* 
82.2 ± 5.1 (3) 
84.6 ± 5.9 (3) 
 
72.2 ± 8.1 (3)* 
84.4 ± 5.9 (4) 
89.6 ± 0.2 (3) 
88.1 ± 4.0 (4) 
92.8 ± 3.2 (5) 
 
83.5 ± 5.1 (7)* 
84.3 ± 3.0 (6)* 
90.3 ± 2.8 (7) 
91.3 ± 3.1 (7) 
94.1 ± 3.1 (6) 
 
67.6 ± 8.1 (5)* 
76.1 ± 7.4 (4) 
86.5 ± 4.2 (4) 
89.1 ± 7.2 (4) 
94.8 ± 7.3 (4) 
 
59.7 ± 7.8 (3)* 
89.9 ± 2.3 (4) 
92.7 ± 1.0 (3) 
95.0 ± 1.2 (4) 
100.4 ± 0.6 (4) 
 
79.7 ± 4.5 (3)* 
87.8 ± 3.6 (3) 
89.2 ± 3.8 (3) 
91.5 ± 4.2 (3) 
91.4 ± 2.3 (3) 
 
84.9 ± 7.7 (3) 
92.6 ± 6.4 (3) 
99.0 ± 6.9 (3) 
94.8 ± 10.1 (3) 
93.0 ± 4.2 (3) 
 
93.5 ± 4.3 (4) 
96.0 ± 5.0 (4) 
94.2 ± 1.4 (4) 
96.7 ± 8.2 (4) 
 
89.8  ± 8.6 (3) 
99.6  ± 7.7 (3) 
97.2  ± 5.6 (3) 
96.1  ± 2.6 (3) 
102.8 ± 4.6 (3) 
 
89.7 ± 3.8 (3) 
94.5 ± 3.0 (3) 
90.5 ± 3.1 (3) 
94.7 ± 1.4 (3) 
 
88.0 ± 1.3 (3)* 
90.8 ± 0.5 (3)* 
97.1 ± 0.9 (3) 
99.7 ± 1.4 (3) 
99.3 ± 1.3 (3) 
 
73.8 ± 3.4 (5)* 
80.5 ± 3.5 (5)* 
83.2 ± 3.9 (5)* 
87.2 ± 3.5 (5) 
92.6 ± 2.1 (5) 
 
81.5 ± 2.1 (8)* 
85.1 ± 2.7 (7)* 
88.5 ± 1.0 (9)* 
91.4 ± 1.1 (9)* 
96.5 ± 1.0 (8) 
 
60.0 ± 4.3 (5)* 
80.7 ± 2.4 (4)* 
82.4 ± 1.2 (5)* 
87.1 ± 2.3 (5)* 
93.4 ± 2.4 (6) 
 
61.6 ± 3.1 (3)* 
80.8 ± 1.6 (3)* 
85.2 ± 2.0 (3)* 
86.9 ± 0.2 (3)* 
95.0 ± 1.8 (3) 
 
89.2 ± 3.1 (3) 
92.3 ± 2.3 (3) 
92.3 ± 1.7 (3) 
95.9 ± 1.5 (3) 
97.3 ± 6.1 (3) 
 
79.1 ± 6.4 (3) 
80.5 ± 6.0 (3) 
86.0 ± 7.6 (3) 
88.9 ± 4.8 (3) 
76.4 ± 11.2 (3) 
 
85.3 ±  9.8 (3) 
86.3 ±  9.8 (3) 
94.1 ±  4.8 (3) 
97.8 ±  4.5 (3) 
 
110.7 ± 13.1 (3) 
108.8 ± 12.9 (3) 
103.5 ±   1.3 (3) 
105.8 ±   4.2 (3) 
117.6 ± 10.4 (3) 
 
94.0± 3.4 (3) 
93.2± 6.1 (3) 
95.8± 3.8 (3) 
93.0± 0.5 (3) 
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Fig. 3-2 Inhibition of proliferation of T84 cells by Kv channel blockers 
Cell proliferation of T84 cells was assessed by BrdU incorporation and cell counting. The 
K+ channel blockers A) TPeA, B) terfenadine, C) BDS-I, and D) quinidine caused dose 
dependent inhibition of proliferation. E) Additional activation of SK4 channels by riluzole 
further enhanced proliferation. Asterisks indicate significant differences when compared to 
control (ANOVA). Experiments were carried out in triplicates. (number of experiments). 
 
Kv channels are active in colonic carcinoma cells 
We screened for the effects of K+ channel blockers in a fluorescence based assay, using the 
voltage sensitive dye FMP. After loading of the cells with FMP, the Kv channel blocker 4-AP 
(50 µM) enhanced fluorescence intensity, due to depolarization of the membrane voltage. 
The effects of individual blockers were analyzed as fraction of the effect of BaCl2 (5 mM), 
which induced maximal depolarization. The largest changes were observed for the Kv 
channel blockers 4-AP (50 µM), quinidine (10 µM), terfenadine (10 µM) and astemizole (5 
µM). This demonstrates a contribution of Kv channels to the overall K+ conductance in T84 
cells (Fig. 3-3A, right panel). K+ channel blockers were also applied in whole cell patch clamp 
experiments. The blockers were used at lower concentration range, in order to achieve best 
specificity. As shown in Fig. 3-3B, C, K+ channel blockers had small but significant effects on 
whole cell conductance and membrane voltage (Vm). Blockers were typically applied in the 
presence of Ringer solution; however, similar effects were also observed when blockers 
were examined in the presence of culture medium (Opti-MEM), i.e. under proliferation assay 
conditions (data not shown). Taken together Kv channels contribute only about 10 - 15% to 
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the total membrane conductance, which is sufficient to support proliferation of T84 cells. 
Similar has been observed in previous studies (6). 
 
 
 
Fig. 3-3 Effects of Kv channel blockers on membrane voltage whole cell 
conductance 
A) Uptake of the voltage sensitive fluorescence dye FMP. Loading of T84 cells with FMP 
induced fluorescence. 4-AP (50 µM) further increased fluorescence intensity due to 
depolarization of Vm. BaCl2 (5 mM) completely inhibited K+ channels, thereby inducing 
maximal depolarization and further fluorescence increase. The right panel shows the 
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summary of the effects of the K+ channel blockers TPeA (50 µM), quinidine (10 µM), 
terfenadine (10 µM), astemizole (5 µM), 4-AP (50 µM), 293B (10 µM), TRAM-34 (100 nM) 
and clotrimazole (100 nM) on FMP fluorescence, relative to the effects of BaCl2. B) Effect 
of TPeA and terfenadine on whole cell currents obtained in T84 cells and summary i/v 
curves in the absence or presence of the inhibitor. C) Summary of the effects of the K+ 
channel blockers on whole cell conductance and membrane voltage, at concentrations as 
indicated above. Concentrations for the other inhibitors were: BDS-I (10 nM), 
charybdotoxin (100 nM), iberiotoxin (10 nM), AVE0118 (10 µM) and AVE1231 (10 µM). 
IC50 values were determined experimentally or were obtained from literature. Asterisks 
indicate significant differences when compared to control (paired Student´s t-test). 
(number of experiments). 
 
Down regulation of Eag1 inhibits proliferation 
Proliferation of T84 cells may be supported by a number of different Kv channels. Although 
patch clamping and expression studies suggested a dominant role of Eag channels, we used 
siRNA-Eag1 to specifically down regulate expression of Eag1 protein. Quantitative analysis 
of gene expression using real time PCR, indicated a significant loss of Eag1 transcripts after 
treatment with siRNA-Eag1 and reduced Eag1 expression was verified by Western blotting 
(Fig. 3-4A). 
 
 
 
Fig. 3-4 Down regulation of Eag1 inhibits cell proliferation and astemizole sensitive 
currents 
A) Suppression of Eag1- mRNA and protein in T84 cells by siRNA-Eag1 but not by 
unrelated siRNA (Lmo2; SK4), or in mock transfected cells. B) Inhibition of cell 
proliferation by siRNA Eag1, but not by unrelated control siRNA. C) Reduced astemizole 
Voltage gated K+ channels support proliferation of colonic carcinoma cells 41
 
sensitive FMP fluorescence (∆FMP) in siRNA Eag1 transfected cells, but not in control 
cells. D). siRNA Eag1 abolished astemizole sensitive Gm (left panel). In contrast, siRNA 
SK4 abolished TRAM-34 sensitive Gm (right panel), which, however, did not affect 
proliferation of T84 cells (shown in B). Asterisks indicate significant difference when 
compared to control (ANOVA, Student’s t-test). Proliferation assays were carried out in 
triplicates. (number of experiments). 
 
We found that down regulation of Eag1 expression inhibited proliferation, while mock 
transfection, unrelated siRNA (for Lmo2 oncogene) or siRNA- inhibition of the Ca2+ activated 
K+ channel SK4 did not reduce cell proliferation (Fig. 3-4B). In the FMP fluorescence assay 
we found a reduced effect of astemizole (5 µM) on membrane voltage, i.e. FMP uptake 
(∆FMP) (Fig. 3-4C). Along this line suppression of astemizole sensitive Eag1 conductance 
was detected in whole cell patch clamp experiments. In contrast TRAM-34 sensitive SK4 
conductance was eliminated by siRNA-SK4, which had no impact on proliferation of T84 cells 
(Fig. 3-4D). Taken together, endogenous Eag1 currents control proliferation of T84 colonic 
carcinoma cells, while endogenous SK4 currents are not relevant for cell growth. 
 
Kv channels control regulation of intracellular pH and Ca2+ signaling, but not cell 
volume 
Kv channels contribute to the negative membrane voltage, which may be crucial for volume 
and pH regulation, as well as proper Ca2+ signaling particularly during cell cycling (6, 15, 77, 
78). We therefore asked if Kv channels enhance proliferation by affecting cell volume or pH 
regulation, or by supporting intracellular Ca2+ signaling. T84 cells were swollen by removing 
120 mmol/l mannitol (Hypo), or were shrunken by adding 120 mmol/l mannitol (Hyper) to an 
isotonic Ringer solution. Swelling and shrinkage was assessed by changes in calcein 
fluorescence (Fig. 3-5A). Repetitive exposure to hypotonic bath solution produced identical 
changes in cell volume (n = 41, data not shown). Cell swelling was not different in the 
presence or absence of Kv channel blockers (Fig. 3-5B,C). We further examined if pH 
recovery from an acid (NH4Cl; 20 mM) load and thus regulation (recovery) of intracellular pH 
is affected by inhibitors of Kv channels. To that end cells were acid loaded using a NH4Cl 
pulse. The slope for initially recovery from cellular acidification was determined in the 
absence or presence of Kv channel blockers. Repetitive acidification under control condition 
showed similar recovery of the intracellular pH (n = 62, data not shown). Recordings of the 
intracellular pH and the summary for the recovery rates demonstrate impaired pH regulation 
in T84 cells when exposed to the Kv channel blockers 4-AP or astemizole (Fig. 3-5D,E). 
These results indicate that Kv channels are important for pH regulation in colonic carcinoma 
cells. pH recovery is primarily due to the function of the Na+/H+ exchanger NHE (6, 79). In 
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fact, blockage of NHE by 5-(N-Ethyl-N-Isopropyl) amiloride (EIPA) inhibited proliferation of 
T84 cells (Fig. 3-5F). 
 
 
 
Fig. 3-5 Kv channels affect pH regulation but not cell swelling 
A) T84 cells were swollen (removal of 120 mmol/l mannitol; Hypo) or shrunken (adding 120 
mmol/l mannitol; Hyper), as assessed by changes in calcein fluorescence. Repetitive 
exposure to hypotonic bath solution produced identical changes in cell volume (n = 41, 
data not shown). B) Kv channel inhibitors 4-AP or TPeA did not affect cell swelling. C) 
Summary of the effects of 4-AP, astemizole and TPeA on cell swelling, as measured by 
calcein fluorescence. D) Original recording of intracellular pH and effect of astemizole on 
pH recovery from acid (NH4Cl) load. E) Summary of the effects of 4-AP and astemizole on 
pH recovery after acid load. F) Effect of the NHE1- inhibitor EIPA on cell proliferation. 
Asterisks indicate significant difference when compared to control (Student’s t-test). 
(number of experiments). 
 
We further examined potential effects of Kv channels on intracellular Ca2+ signaling. As 
shown in Fig. 3-6, baseline intracellular Ca2+ in resting cells was not affected by Kv channel 
inhibitors. We stimulated T84 cells with the muscarinic secretagogue carbachol (CCH, 100 
µM). This induced a release of Ca2+ from intracellular stores (transient peak response) and a 
subsequent influx through store operated Ca2+ channels (Ca2+ plateau) (original traces in Fig. 
3-6). 
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Fig. 3-6 Kv channels affect carbachol induced Ca2+ signaling 
A) Original recordings of [Ca2+]i in fura-2 loaded T84 cells and effects of carbachol (CCH; 
100 µM) and 4-AP on transient (store release; peak) and persistent (influx; plateau) Ca2+ 
increase. Right panel: Summary of the effects of 4-AP (50 µM) and TPeA (5 µM) on Ca2+ 
peak and plateau. B) Original recordings of the effects of carbachol and astemizole. Right 
panel: Summary of the effects of BDS-I (10 nM) and astemizole (0.5 µM) on Ca2+ peak 
and plateau. C) Original recordings of the effects of carbachol on control cells and cells 
treated with siRNA Eag1 or siRNA SK4. Right panel: Summary of the effects of siRNA 
Eag1 or siRNA SK4 on Ca2+ peak and plateau. Asterisks indicate significant difference 
when compared to control (ANOVA, Student’s t-test). (number of experiments). 
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Both Ca2+ peak and plateau were significantly reduced in the presence of the non-selective 
Kv blockers 4-AP (50 µM) and TPeA (5 µM) (Fig. 3-6A). Similar effects on [Ca2+]i were 
observed with the Eag1 inhibitor astemizole (0.5 µM) and the KV3.4 blocker BDS-I (10 nM) 
(Fig. 3-6). Moreover, inhibition of Eag1 expression by siRNA also attenuated Ca2+ signaling, 
while siRNA - suppression of SK4 had no effects on the carbachol induced Ca2+ signaling 
(Fig. 3-6B,C). The contribution of K+ channels to Ca2+ signaling was further confirmed by the 
nonselective K+ channel inhibitor Ba2+, which also attenuated Ca2+ signaling T84 cells (data 
not shown). Taken together, Kv channels affect intracellular Ca2+ signaling probably by their 
hyperpolarizing effects which provides a driving force for Ca2+ release and influx through 
store operated Ca2+ channels (SOCs) (80, 81). 
 
Although upregulation of voltage gated Ca2+ channels (VOCC) in T84 cells has been reported 
previously (82), they are probably of limited importance for proliferation since we did observe 
any impact of the VOCC inhibitor calciseptine had no effect on proliferation (Fig. 3-7A). 
Moreover, agonist (carbachol) induced Ca2+ signaling was not affect by calciseptine in either 
T84 or HT29 cells (Fig. 3-7B,C). 
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Fig. 3-7 Voltage gated Ca2+ channels do not affect proliferation or Ca2+ signaling in 
colonic cancer cells 
A) Cell proliferation of T84 cells was not affected by the inhibitor of L-type Ca2+ channels, 
calciseptine. carbachol (CCH, 100 µM) induced Ca2+ increase in T84 (B) or HT29 (C) cells 
was not affected by calciseptine. (number of experiments). 
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Discussion 
 
K+ channels and cancer 
Several types of K+ channels have been detected in human cancers (6). Ca2+ activated K+ 
channels were found in prostate cancer (83), uterine cancer (84), human gliomas (85), 
gastric cancer (86), pituitary adenomas (87) and colorectal cancer (16, 83, 88). In other 
tumors proliferation is supported by ATP sensitive Kir channels or two-pore (2P)-domain 
channels (89-91). Nevertheless, in the majority of cancer cells, Kv channels were correlated 
to proliferation (19, 41, 64, 65, 92-94). Other data from human biopsies and carcinogen 
treated mice suggest high levels of Eag1 protein in colonic cancers, which is not observed in 
the native colon (76). Also in the present study we found a role of Kv channels for 
proliferation of cultured colonic carcinoma cells. Thus, the results obtained in T84 cells may 
be representative for the changes that occur in the native colon during carcinogenesis.  
 
Kv but not other K+ channels control proliferation in T84 cells 
Kv channels operate at rather depolarized membrane voltages (Vm), which are typically not 
found in terminally differentiated epithelial cells (41, 64). The depolarized Vm of carcinoma 
cells provides the basis for activation of Kv channels (95). When studied under proliferative 
conditions, serum containing culture medium depolarizes Vm (96). In vivo, cells are exposed 
to 20 – 30 g/l protein present in the interstitial fluid, which may depolarize Vm and allow for 
activation of Kv channels in carcinoma cells in situ (97). Remarkably the contribution of Kv 
channels to the overall conductance in T84 cells was only 10 – 15%. However, this is in line 
with previous reports, which indicate that pro-proliferative K+ currents are often of smaller 
amplitude, while large K+ currents are detected during apoptosis (6, 98). 
 
Because of the limited specificity of most K+ channel inhibitors (99), we also used siRNA to 
identify the K+ channels in charge of cell proliferation. Only Kv channels appear to affect cell 
proliferation, although other K+ channels are expressed and functional in T84 colonic 
carcinoma cells, such as SK4 channels. Obviously Eag1 and other Kv channels operate well 
in proliferating T84 cells, while SK4 channels only support proliferation after additional 
activation by riluzole. Surprisingly, even the K+ ionophore valinomycin increased proliferation 
of T84 cells when applied at very low (100 fM) concentrations (unpublished data from the 
author’s laboratory). We suggest that the oncogenic potential of Kv channels is linked to the 
K+ channel function. This has been demonstrated recently for TASK3 channels (100). In 
principle, any type of K+ channel may be able to support proliferation, depending on 
additional cell specific properties that determine K+ channel activity. 
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How do Kv channels control cell proliferation? 
The present study was performed to determine the mechanism by which K+ channels affect 
cell growth. Progression through the cell cycle is dependent on K+ channels and blocking of 
these channels causes inhibition of proliferation (15). This clearly suggests a cell cycle 
specific function of K+ channels. Apart from this specific role, Kv channels may also have 
homeostatic functions in T84 cells. The present data demonstrate an impact of Kv channels 
on intracellular Ca2+ signaling and pH regulation. The importance of pHi for cell proliferation 
and cancer development is well established (77). pHi is varying during the cell cycle and 
need to be tightly controlled, probably by the Na+/H+ exchanger NHE1 (79). The experiments 
with the NHE – blocker EIPA presented here, clearly show the importance of NHE for cell 
proliferation. Na+/H+ exchange requires low intracellular Na+ concentrations, and Vm need to 
stay hyperpolarized, Both is facilitated by the Na+/K+ - ATPase in parallel with K+ channels. 
Kv channels may provide a K+ recycling pathway and hyperpolarize the membrane voltage, 
and may thus contribute indirectly to pH regulation.  
 
Equally important is the control of intracellular Ca2+ in proliferating cells, especially during the 
mitotic cell cycle (79). We found that agonist induced Ca2+ release and influx of Ca2+ through 
SOCs, dependents on the function of Kv channels. Thus Ca2+ dependent activation of ion 
currents was reduced significantly by 3.2 ± 0.5 nA (100 µM 4-AP, n = 4) and 2.8 ± 0.4 nA (5 
µM astemizole, n = 5). It has been demonstrated by others (81) that depolarization of the 
membrane voltage reduces Ca2+ signaling. Since inhibitors of Kv channels depolarize Vm, 
this may explain why Ca2+ signaling is affected. Furthermore, a previous study demonstrated 
that activation of store operated Ca2+ Channels (SOCs) in T84 cells induces proliferation (80). 
Moreover, capacitative Ca2+ influx through SOCs is reduced at acidic pH (101). Since Kv 
channels also affect intracellular pH, this may provide an independent mechanism, by which 
Kv channels affect intracellular Ca2+ signaling. Voltage gated Ca2+ channels (VOCC) are 
probably not related to the effects of Kv channel inhibitors, although L-type Ca2+ channels are 
expressed in T84 colonic carcinoma cells (82). This is further substantiated by the fact that the 
L-type Ca2+ channel inhibitor calciseptine did not reduce proliferation or Ca2+ signaling (Fig. 
3-7). Taken together hyperpolarization of Vm by Kv channels may be necessary to maintain 
pH regulation and Ca2+ signaling, which allows progression through the G1 phase of the cell 
cycle (15, 78). 
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Chapter 4 
 
 
Expression of voltage gated potassium channels in human and mouse colonic 
carcinoma 
 
Abstract 
 
Purpose: Voltage gated Kv potassium channels like ether-á-go-go (Eag) channels have been 
recognized for their oncogenic potential in breast cancer and other malignant tumors. 
 
Experimental design: We examine the molecular and functional expression of Kv channels in 
human colonic cancers and colon of mice treated with the chemical carcinogens DMH and 
MNU. The data were compared with results from control mice and animals with chemically 
induced DSS colitis. 
 
Results: Electrogenic salt transport by amiloride sensitive Na+ channels and cAMP activated 
CFTR Cl- channels were attenuated during tumor development and colitis, while Ca2+ 
dependent transport remained unchanged. Kv channels, in particular Eag1 were enhanced 
during carcinogenesis. Multiplex RT-PCR showed increased mRNA expression for Kv1.3, 
Kv1.5, Kv3.1 and members of the Eag channel family after DMH and MNU treatment. Eag1 
protein was detected in the malignant mouse colon and human colonic cancers. Genomic 
amplification of Eag1 was found in 3.4% of all human colorectal adenocarcinoma and was an 
independent marker of adverse prognosis. 
 
Conclusions: The study predicts an oncogenic role of Kv and Eag channels for the 
development of colonic cancer. These channels may represent an important target for a 
novel pharmacotherapy of colonic cancer. 
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Introduction 
 
Membrane ion channels are essential for cell proliferation and have a role in the 
development of cancer. A substantial body of evidence exists that voltage gated potassium 
(Kv) channels have an oncogenic function (102-105). Moreover, during carcinogenesis 
changes in expression or activity of ion channels may affect electrolyte transport properties in 
epithelia, similar to the changes observed during inflammation (102). K+ channels are 
involved in the development of cancer of prostate, colon, lung and breast (102, 106). K+ 
channels were identified in different cancer tissues, such as Ca2+- activated and voltage-
gated K+ channels (Kv channel), the ether-à-go-go (Eag) family and 2P-domain K+ channels 
(102). However, Kv channels seem to play a central role in tumor cells, particularly in those 
of epithelial origin (102-104). Cell cycle regulated Eag1 channels, normally only expressed in 
excitable tissues and oocytes are also found in cancer cells (105, 107, 108). Activation of 
these channels induces hyperpolarization of the plasma membrane, which may be essential 
for cell proliferation (103). Hyperpolarization of the membrane voltage facilitates Ca2+ 
signaling, and is necessary for regulation of intracellular pH and cell volume. All of these 
parameters, Ca2+, pH and volume clearly affect cell proliferation (102, 103, 109). 
Most studies on the oncogenic role of ion channels have been performed in cell lines, leaving 
open their relevance for tumor development in vivo. We therefore designed the present study 
to examine the role of ion channels for tumor development in vivo in carcinogen treated mice. 
DMH and MNU were used as carcinogenic agents. Dimethylhydrazine (DMH) is organotropic 
for the rodent colon. It is metabolized to methylazoxymethanol and methyldiazonium and 
causes methylation of nucleotides (110). Rectal application of N-methyl-N-nitrosourea (MNU) 
causes direct alkylation of DNA and also induces colonic tumors (111, 112). During the 
development of colonic cancer, alterations in colonic electrolyte transport have been reported 
in previous studies (113, 114). Electrolyte transport appears to be affected in the pre-
malignant colon, which may contribute to the irregularities in defecation, often observed in 
patients with human colonic cancer. We found that electrolyte transport was affected in colitis 
and during carcinogenesis. However, over-expression of cell cycle regulated Eag1 K+ 
channels was only found in the pre-malignant mouse colon and in human colonic cancers. 
 
Material and Methods 
 
Patients, tumor material for FISH analysis, biological samples 
386 surgically resected colorectal adenocarcinomas were selected from the files of the 
Institutes of pathology of the University of Basel and from the Triemli Hospital, Zürich, 
Switzerland. Tissue micro array was constructed as previously described (115). Specimens 
were kept anonymous, and experiments were conducted according to the guidelines of the 
ethical committee of the University of Basel. pTNM stage was determined according to the 
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International Union Against Cancer (116). Colon biopsies were obtained from patients 
hospitalized at the children’s hospital of the University of Freiburg/Germany and the 
department of internal medicine of the University of Regensburg, according to the guidelines 
of the local ethical committee. 
 
DMH, MNU, and DSS treatment 
Animal studies were conducted according to the guidelines of the National Institute of Health 
guidelines for the care and use of animals in research and the German laws on protection of 
animals. C57BL/6NCrl mice were obtained from Charles River (Sulzfeld, Germany). DMH or 
control saline were dissolved in 0.9% saline and injected s.c. into the groin at a dose of 40 
mg/kg once a week for 5 wks. Proximal and distal colons were removed for RNA and protein 
isolation, histology and functional measurements. For MNU treatment, mice were 
anaesthetized by intraperitoneal injection of Ketamin/Xylazin (120 mg/8 mg/kg * bodyweight). 
MNU (2.6 mg/0.4 ml 0.9% NaCl solution) was given intrarectally two times a week for 2 
weeks and once a week for additional 4 weeks. For RPD measurements a catheter (PE 10 
tubing) containing ringer solution was inserted 2 cm into the rectum, and perfused 
continuously at a rate of 1 ml/h. The catheter was attached via an agar bridge to an AgCl- 
electrode. A subcutaneous needle positioned in the abdomen and connected via an agar 
bridge served as the reference electrode. For DSS treatment of BALB/cOlaHsd mice, 3 % 
DSS was added to drinking water for 7 -10 days. 
 
Histology 
Mice were sacrificed under CO2 inhalation; the colon was removed and stripped 
mechanically from submucosal tissues. Tissues were fixed for 20 min with 4% 
paraformaldehyde, 0.1% glutaraldehyde, 15% picric acid in PBS (pH 7.4) followed by a 12 h 
incubation in 4% paraformaldehyde, 15% picric acid in PBS (pH 7.4) at 4°C. Tissues were 
washed in PBS and incubated in 10%, 20% and 30% sucrose solutions, dehydrated and 
embedded in paraffin. Paraffin-embedded tissues were cut at with a rotary microtome (Leica 
Mikrotom RM 2165, Wetzlar, Germany). Sections were de-waxed and re-hydrated and 
stained with hematoxylin and eosin. Some tissues were chock frozen in iso-pentan, 
sectioned at 5 µm, fixed with 4% paraformaldehyde in PBS (pH 7.4) and stained with 
hematoxylin. 
 
Ussing chamber experiments 
Stripped colon was put into ice cold bath solution (mM: NaCl 145, KH2PO4 0.4, K2HPO4 1.6, 
d-glucose 6, MgCl2 1, Ca-gluconate 1.3, pH 7.4) containing amiloride (20 µM) and 
indomethacin (10 µM). Tissues were mounted into an Ussing chamber with a circular 
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aperture of 0.785 mm2. Luminal and basolateral sides of the epithelium were perfused 
continuously at a rate of 5 ml/min. Bath solutions were heated to 37 °C, using a water jacket. 
Experiments were carried out under open circuit conditions. Data were collected continuously 
using PowerLab (AD-Instruments, Australia). Values for transepithelial voltages (Vte) were 
referred to the serosal side of the epithelium. Transepithelial resistance (Rte) was determined 
by applying short (1 s) current pulses (∆I = 0.5 µA). Rte and equivalent short circuit currents 
(ISC) were calculated according to Ohm’s law (Rte = ∆Vte/∆I, ISC = Vte/Rte). 
 
Crypt cell isolation and expression analysis of ion channels in colonic epithelial cells 
Colonic crypts were isolated from an inverted colon in Ca2+ free buffer solution. Total RNA 
was prepared from isolated crypts (NucleoSpin, Macherey-Nagel, Düren, Germany). After 
reverse transcription, semi- quantitative multiplex RT-PCR was performed. The following 
primers (accession number) were used: mKv1.3 (NM_008418): 5´-
GTACTTTGACCCACTCCGC -3´ (s), 5´-GCAAGCAAAGAACCGCACC-3´ (as); mKv1.5 
(NM_145983): 5´-GCTACTTCGATCCCTTGAG -3´ (s), 5´-GCTCAAAAGTGAACCAGATC-3 
(as); mKv3.1 (NM_008421): 5´-CCAGACGTACCGCTCGAC 3´ (s), 5´-
CGAACAGCGCCCAGATGC-3´ (as); mEag1 (NM_010600): 5´-
GGATTCTGCAAGCTGTCTG-3´ (s), 5´-GTAGAAGGTCAGGATCAAG-3´ (as); hEag1 (NM 
172362, NM 002238): 5´-CGCATGAACTACCTGAAGACG-3´ (s), 5´-
TCTGTGGATGGGGCGATGTTC-3 (as); mErg1 (NM_172057): 5´-
CCTCGACACCATCATCCGC-3´ (s), 5´-GTCCGCACAGATGATTCCC-3´ (as); mElk1 
(NM_001031811): 5´-GGTTTCCCCATAGTCTACTG-3´ (s), 5´- 
CAAAATGAGCCAGTCCCAGC-3´ (as); mENaCα (NM_011324): 5´-
CCTTGACCTAGACCTTGACG-3´ (s), 5´- CGAATTGAGGTTGATGTTGAG-3´ (as); mENaCβ 
(NM_000336): 5´-CAATAACACCAACACCCACG-3´ (s), 5´- GAGAAGATGTTGGTGGCCTG-
3´ (as); mENaCγ (NM_011326): 5´-GCACCGACCATTAAGGACC-3´ (s), 5´-
GCCTTTCCCTTCTCGTTCTC-3´ (as); mCFTR (NM_021050): 5´-
GAATCCCCAGCTTATCCACG-3´ (s), 5´- CTTCACCATCATCTTCCCTAG -3´ (as). PCR 
reactions were performed at 94˚C for 2 min, 28-38 cycles at 94˚C for 30 s, annealing 
temperature 56°C for 30 s and 72˚C for 1 min using GoTaq DNA Polymerase (Promega, 
Mannheim, Germany). Expression of mRNA of each gene product was normalized against β-
actin expression. 
 
Detection of Eag1 protein 
Isolated crypt cells from distal and proximal colon were lysed and total protein (50 µg) was 
resolved by 7% SDS-PAGE, transferred by semi- dry blotting to Hybond-P (Amersham, 
Freiburg, Germany) and incubated with rabbit anti-Kv10.1 (Eag1) (Alomone labs, Israel) and 
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rabbit anti- actin antibodies (Sigma, Taufkirchen, Germany). Proteins were visualized using a 
goat anti-rabbit IgG conjugated to horseradish peroxidase (Acris Antibodies, Hiddenhausen, 
Germany) and ECL Advance Detection Kit (Amersham). Signals were detected by Fluor-STM 
MultiImager system (Bio-Rad Laboratories, Hercules, USA) and analyzed with Multi-Analyst 
software (Bio-Rad). Expression of EAG1protein was normalized against actin protein 
expression. 
 
FISH analysis 
The bacterial artificial chromosome (BAC) RP11-75i2, containing parts of the Eag1gene 
sequence at 1q32.2-3 was obtained from the German Resource Centre for Genome 
Research (RZPD; Berlin, Germany). 1 µg of purified plasmid DNA was labelled using a 
modified Bio Nick kit (Invitrogen, Carlsbad, CA). Nick translation was performed at 16°C for 
90 min. The labeled FISH probe was purified by precipitation and re-dissolved in 50 µl H20. 
Paraffin removal (3x 5min in Xylene followed by 2x 2min ethanol 95% and air-drying) and 
enzymatic tissue pretreatment (Vysis pretreatment solution, 80°C, 15 min) of tissue sections 
mounted on glass slides was performed in a VP2000 Processor device (Vysis, Downers 
Grove, IL). A premixed hybridization cocktail containing 0.5 µl centromere 1 probe (CEP 1 
SpectrumOrange labeled; Vysis), 1.5 µl Eag1 probe, 1 µl Cot DNA (Invitrogen), and 7 µl 
hybridization buffer (Vysis) was added to each slide with denatured target DNA. Probes were 
allowed to hybridize overnight at 37°C in a humidified chamber. After washing steps, Eag1 
probe was detected using the Dig detection kit (Roche Diagnostics). Amplification was 
defined as a signal ratio of Eag1 probe / centromere 1 of at least 2 and at least 4 gene 
signals. 
 
Materials and statistical analysis 
All used compounds were of highest available grade of purity. DMH, MNU, amiloride, 4-AP, 
astemizole, carbachol, and IBMX were from Sigma-Aldrich (TaufKirchen, Germany). DSS 
was from ICN (Eschwege, Germany). Forskolin and 293B were gifts from Aventis Pharma 
(Frankfurt, Germany). Student’s t-test (for paired or unpaired samples as appropriate) and 
analysis of variance (ANOVA) were used for statistical analysis. P < 0.05 was accepted as 
significant. Survival curves were plotted according to Kaplan-Meier. A log rank test was 
applied to examine the relationship between alterations clinicopathological data or Eag1 
amplification status and overall survival. Patients were censored at the time of their last 
clinical control. Cox proportional hazard model with stepwise selection of the covariates was 
used to determine the parameters with greatest influence on the risk of recurrence and 
progression. 
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Results 
 
Histopathology 
From week 12 on, DMH treated animals showed a significantly reduced weight increase. 
MNU treated mice also demonstrated a reduced body weight and a growth delay compared 
to untreated mice. Frequently the animals developed diarrhea upon treatment with 
carcinogens. 6 to 8 weeks after DMH treatment, local mucosal infiltration of leucocytes 
indicated inflammatory processes in distal colon (Fig. 4-1A,B). After 10 and 12 weeks 
changes of mucosal architecture such as tortuous crypts and crypt loss were observed in 
distal colon (Fig. 4-1C). No obvious histological changes were found in the proximal colon. 
Rectal MNU application 4 times in 2 weeks induced hyperplastic crypts in distal colon, 
indicated by an increase of crypt heights and decreased number of globlet cells along the 
cryptal wall. Moreover nuclear to cytoplasmic ratio was increased (Fig. 4-1D).  
 
 
 
Fig. 4-1 Effects of DMH, MNU, and DSS treatment on colonic architecture 
A) Hematoxylin and eosin staining of control distal colon. B) Infiltration by inflammatory 
cells of distal colonic mucosa after DMH treatment. C) Loss of crypts in distal colonic 
mucosa of DMH treated mice. D) Hyperplastic crypts in distal colon after MNU treatment. 
Bars = 50 µm. 
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Cellular redistribution and nuclear accumulation of ß-catenin was not clearly correlated with 
carcinogen treatment and was therefore not used as an independent marker for 
carcinogenesis (data not shown). Mucosal infiltration by inflammatory cells was observed in 
the proximal colon. After 8 treatments (week 6), extension of the Lamina submucosea and M. 
submucosea, and dysplasia of distal colonic mucosa were observed. Administration of DSS 
caused severe changes of the tissue architecture, ulceration, and inflammatory cell 
infiltration, areas of complete epithelial denudation as well as submucosal edema in distal 
and proximal colon. Thus, inflammation and carcinogenesis induced by chemicals is clearly 
demonstrated by histological changes. 
 
DMH, MNU and DSS treatment inhibits Na+ absorption and Cl- secretion 
In essence, electrogenic ion transport in the colon is due to Na+ absorption by amiloride 
sensitive Na+ channels (ENaC) and cAMP- or Ca2+- induced Cl- and K+ secretion. The 
amount of electrogenic Na+ absorption is determined by inhibition with amiloride and 
calculation of the amiloride sensitive short circuit current Isc Amil (Fig. 4-2A). DMH treatment 
reduced ISC Amil in distal colon 6 and 8 weeks after the first DMH injection, which recovered at 
week 10 and 12 (Fig. 4-2A,B). Similar effects on amiloride sensitive Na+ absorption were 
seen in MNU treated mice. Rectal potential difference (PD) measurements in vivo after 2 and 
6 weeks of MNU treatment showed a reduced rectal PD, due to attenuated amiloride 
sensitive transport (Fig. 4-2C). Ussing chamber experiments and ISC measurements 
confirmed reduced Na+ absorption in distal colon of MNU treated mice (19.6 ± 4.3 µA/cm2; n 
= 11), when compared to control mice (57.8 ± 9.6 µA/cm2; n = 13) (Fig. 4-2D). Also in the 
inflamed colon, during treatment with DSS amiloride sensitive rectal PD was significantly 
reduced from -7.2 ± 0.58 mV (n = 7) to -4.9 ± 0.73 mV (n = 10). 
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Fig. 4-2 Change of amiloride sensitive transport by carcinogens 
A) Ussing chamber recordings of the transepithelial voltage. Amiloride (20 µM), a specific 
inhibitor of epithelial Na+ channels reduced Vte and increased ∆Vte due to inhibition of Na+ 
absorption. The effect of amiloride on Vte was reduced after 6 weeks of DMH treatment. B) 
Amiloride (20 µM) sensitive ISC (ISC Amil) was reduced in Ussing chamber experiments 6 
and 8 weeks after initial DMH injection. C) Rectal potential difference (RPD) 
measurements showed reduced effects of amiloride (RPDAmil), 2 and 6 weeks after rectal 
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application of MNU. D) Ussing chamber experiments confirmed reduced ISC Amil in distal 
colon, 6 weeks after rectal application of MNU. Asterisks indicate significant differences 
compared to control (Student´s t-test). (number of mice). 
 
Increase in intracellular cAMP by IBMX (100 µM) and forskolin (2 µM) induced Cl- secretion 
(ISC cAMP) in proximal and distal colon, by activation of the cystic fibrosis transmembrane 
conductance regulator (CFTR). DMH caused a reduced ISC cAMP response in both proximal 
and distal colon at week 6 and 8. In contrast, later stages (week 12) ISC cAMP was significantly 
elevated in proximal colon (Fig. 4-3A,B). It is well known that basolateral cAMP- dependent 
activation of the cotransporter NKCC1, and 293B sensitive KCNQ1 K+ channels (ISC 293B) 
facilitate CFTR dependent Cl- secretion. Accordingly DMH treatment inhibited ISC 293B in cAMP 
stimulated proximal colon at week 6 and increased ISC 293B at week 12 (Fig. 4-3C). 
 
 
 
Fig. 4-3 Treatment with DMH, MNU and DSS reduced CFTR dependent Cl- secretion 
A) IBMX and forskolin increased intracellular cAMP and activated CFTR dependent Cl- 
secretion. In proximal colon, cAMP induced ISC (ISC cAMP) was reduced 6 weeks after DMH 
injection, but was and elevated after 12 weeks. B) Summary of the effects of DMH on ISC 
cAMP in distal colon. C) The 293B sensitive ISC (ISC 293B) was reduced 6 weeks after DMH 
injection and was elevated after 12 weeks. D) Increase in rectal PD by IBMX and forskolin 
(RPDcAMP) was reduced in MNU and DSS treated mice, respectively. Asterisks indicate 
significant differences compared to control (Student´s t-test). (number of mice). 
 
Similar to DMH in the early phase, MNU and DSS also reduced cAMP dependent Cl- 
secretion in RPD measurements (Fig. 4-3D). This was further confirmed in Ussing chamber 
recordings. Here, cAMP activated transport was significantly attenuated by 62.3 ± 5.3 µA/cm2 
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(n = 14) in MNU treated animals and by 174.3 ± 18.2 µA/cm2 (n = 7) in DSS treated mice. In 
contrast, Ca2+ activated Cl- secretion, stimulated by carbachol (CCH, 100 µM) and blockage 
by niflumic acid (NFA, 100 µM) remained unchanged (data not shown). Hence electrogenic 
Na+ absorption via ENaC and cAMP dependent Cl- secretion by CFTR are changed during 
inflammation and carcinogenesis, while Ca2+ activated Cl- secretion remains unaffected. 
Since both ENaC and CFTR are the major determinants for net fluid transport in the colon, 
these changes are likely to affect digestive functions of the colon. 
 
Carcinogens induce voltage gated K+ channels 
A major goal of the present study was to identify potential oncogenic ion channels during 
inflammation and carcinogenesis of the colonic epithelium. It is well established that 
proliferation of cancer cells and metastasis require the activity of plasma membrane K+ 
channels (102, 103). We investigated the function of Kv channels in the pre-malignant colon 
using the non-selective Kv channel inhibitor, 4-aminopyridine (4-AP, 100 µM) and the 
inhibitor of the Eag channel family, astemizole (5 µM). Application of both 4-AP and 
astemizole had only minor effects on ISC in control animals, but inhibited ISC significantly in 
proximal and distal colon of DMH treated mice (Fig. 4-4A,B). These results suggest that 
DMH treatment induced activation of Kv and Eag related K+ channels in both distal and 
proximal colon. Similar results were obtained in distal colon of MNU treated mice, where Isc 
was significantly reduced by 4.3 ± 0.54 µA/cm2 (n = 14). The inflamed (DSS) colon did not 
exhibit Kv channel activity in Ussing chamber recordings and showed only small RPD 
changes upon application of 4-AP (data not shown). In summary, Kv channels and cell cycle 
regulated Eag channels were clearly detected in the pre-malignant colon, but were absent in 
the inflamed colon. 
 
Expression of ion channel mRNA in crypt cells of DMH, MNU and DSS treated mice 
Since we detected changes in electrolyte transport as well as enhanced Kv channel activity 
in the pre-malignant colon, we investigated molecular expression of the underlying ion 
channels. Total RNA was prepared from freshly isolated crypt cells of proximal and distal 
colon of DMH, MNU and DSS (each n = 6) treated animals and control mice. Changes in ion 
channel expression relative to the control group were calculated. We found a small but 
significant increase in the mRNA expression for α, β and γ subunits of ENaC in DMH treated 
animals. No changes in expression of CFTR could be detected (Table 4-1). Thus changes in 
Na+ absorption and Cl- secretion due to the DMH treatment are not explained by changes in 
transcript expression of the respective ion channels but are due to other secondary changes 
(c.f. discussion). Enhanced 4-AP sensitive K+ currents detected in carcinogen treated 
animals may also be caused by enhanced expression of Kv channels. In fact, mRNAs 
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encoding the channels Kv3.1, Kv1.3 and Kv1.5 were clearly up regulated in both distal and 
proximal colonic crypt cells of DMH and MNU treated animals. Moreover, corresponding to 
the enhanced astemizole sensitive currents (Fig. 4-4A, B), we detected enhanced mRNA 
expression of ether-á-go-go subtypes Eag1, Erg1 and Elk1 in the pre-malignant proximal and 
distal colon of DMH and MNU treated mice, but not in the inflamed (DSS) colon (Table 4-1). 
 
Table 4-1 Changes in ion channel mRNA expression in crypt cells of proximal and 
distal colon of DMH, MNU and DSS treated mice 
Expression of mRNA was normalized against β-actin expression and changes relative to 
the control group were calculated. Asterisk indicates significant difference to control 
(Student´s t-test). n.c. = no change. Number of mice is given in parentheses 
 
 
DMH and MNU treatment increased expression of Eag1 protein 
Cell cycle dependent regulation of Eag1 is well established, and so far expression of the 
channel was only found in cancer cells but not in normal epithelial tissues (108). Because 
DMH treatment induced an astemizole sensitive ISC and increased Eag1 mRNA expression in 
proximal and distal colon, we also examined protein expression in isolated crypt cells. In the 
control group, Western blot analysis showed no uniform Eag1 expression in crypt cells (Fig. 
4-4C). In contrast in crypt cells of DMH treated mice, Eag1 protein was well detected in 
proximal and distal colon (Fig. 4-4C). The carcinogen MNU enhanced Eag1 expression in the 
proximal colon, while no changes were observed in the inflamed colon (DSS), as indicated 
by densitometric analysis relative to actin staining (Fig. 4-4D). 
 
gene 
 
DMH week 6 
 
DMH week 8 
 
DMH week 10 
 
DMH week 12 
 
MNU week 6 
 
DSS 
 
proximal colon 
ENaCα n.c. (5/6) n.c. (4/6) n.c. (6/6) -0.57 ± 0.06 (4/5)* n.c. (6/6) n.c. (4/6) 
ENaCβ -0.45 ± 0.08 (5/5)* n.c. (6/6) n.c. (6/5) 2.65 ± 0.97 (5/6)* n.c. (5/6) n.c. (4/6) 
ENaCγ n.c. (6/5) n.c. (6/4) n.c. (6/5) 9.75 ± 4.27 (5/5)* n.c. (6/6) 2.21 ± 0.62 (4/6)* 
CFTR n.c. (5/6) -0.77 ± 0.07 (4/5)* n.c. (6/5) n.c. (6/6) n.c. (6/6) n.c. (4/6) 
Kv1.3 n.c. (5/6) 13.59 ± 4.27 (4/6)* n.c. (6/6) n.c. (5/6) n.c. (6/6) n.c. (4/6) 
Kv1.5 n.c. (6/6) n.c. (6/6) n.c. (6/6) n.c. (5/5) 3.13 ± 0.85 (5/6)* n.c. (4/6) 
Kv3.1 n.c. (3/3) 6.19 ± 1.64 (3/3)* 1.36 ± 0.43 (6/6)* 4.03 ± 1.31 (4/5)* 1.41 ± 0.60 (6/6)* n.c. (4/6) 
Eag1 n.c. (5/6) n.c. (5/4) 2.04 ± 0.59 (4/4)* 8.15 ± 2.06 (4/5)* n.c. (6/6) n.c. (4/6) 
Erg1 1.96 ± 0.80 (6/6)* 6.44 ± 2.17 (3/3)* 8.64 ± 1.47 (3/3)* 30.38 ± 2.81 (3/3)* n.c. (6/6) n.c. (4/6) 
Elk1 n.c. (6/6) 1.09 ± 0.37 (5/5)* 2.83 ± 1.42 (5/3)* 2.25 ± 0.76 (4/5)* -0.73 ± 0.14 (5/6)* n.c. (3/6) 
 
distal colon 
ENaCα n.c. (6/6) n.c. (5/5) n.c. (6/6) -0.54 ± 0.08 (5/4)* n.c. (6/6) -0.79 ± 0.08 (4/5)*
ENaCβ -0.55 ± 0.09 (5/6)* n.c. (5/5) n.c. (6/6) 2.54 ± 0.56 (5/6)* n.c. (6/5) n.c. (4/6) 
ENaCγ n.c. (6/5) n.c. (5/5) n.c. (6/6) 5.60 ± 2.22 (5/5)* n.c. (6/5) 1.14 ± 0.47 (4/4)* 
CFTR n.c. (5/6) 0.61 ± 0.11 (5/6)* n.c. (6/6) n.c. (6/6) n.c. (6/6) n.c. (4/6) 
Kv1.3 n.c. (6/6) n.c. (6/6) n.c. (6/6) n.c. (5/6) 15.32 ± 7.48 (5/4)* 4.13 ± 1.57 (4/5)* 
Kv1.5 7.52 ± 1.86 (6/6)* n.c. (6/6) n.c. (6/6) n.c. (5/5) n.c. (6/6) n.c. (4/6) 
Kv3.1 n.c. (3/3) 1.80 ± 0.65 (3/3)* 0.93 ± 0.29 (3/3)* 1.06 ± 0.17 (3/3)* n.c. (6/5) n.c. (4/6) 
Eag1 n.c. (6/6) n.c. (5/5) n.c. (6/5) 2.65 ± 0.83 (4/4)* n.c. (6/6) n.c. (3/6) 
Erg1 4.44 ± 0.37 (3/3)* n.c. (5/5) 1.41 ± 0.22 (3/3)* 2.78 ± 2.12 (3/2)* 2.78 ± 1.14 (6/6)* n.c. (4/6) 
Elk1 n.c. (6/6) n.c. (6/6) n.c. (6/6) n.c. (6/6) n.c. (5/5) n.c. (4/6) 
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Fig. 4-4 Treatment with carcinogens enhanced expression of voltage-gated K+ 
channels 
In proximal (A) and distal (B) colon, application of 4-AP and astemizole indicated 
enhanced activity of voltage-gated K+ channels after treatment with carcinogens. C) 
Western blot analysis of Eag1 (111 kDa) and ß-actin (42 kDa) expression in brain 
(positive control) and crypt cells of proximal and distal colon of control, DMH and MNU 
treated mice. D) Summary of the changes in Eag1 expression (normalized against ß-
actin) in crypt cells of DMH, MNU and DSS treated mice. Asterisks indicate significant 
differences compared to control (Student´s t-test). (number of mice). 
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Eag1 protein expression in human carcinomas and diverticulitis  
Eag1 expression was analysed by RT-PCR in biopsies of two colorectal carcinomas and the 
Eag1 transcript variants 1 and 2 were found in the centre of the carcinoma as well as in the 
macroscopically unaffected periphery. However, no expression of Eag1 mRNA was found in 
the colon of a healthy volunteer (Fig. 4-5A). 
 
 
 
Fig. 4-5 Eag1 is expressed in colonic crypt cells of patients with cancer and 
diverticulitis 
 A) RT-PCR showed mRNA expression of the two variants of Eag1 (variant 1, 560 bp, 
variant 2, 479 bp) in the centre and peripheral tissue of the cancer in two patients. In a 
colonic biopsy of a healthy volunteer, no Eag1 transcripts were detected. B) Total protein 
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was isolated from T84 colonic cancer cells and from crypt cells derived from patients with 
different diagnosis. Colonic biopsies of healthy patients served as controls. C) 
Fluorescence in situ hybridization of a colorectal adenocarcinoma with Eag1 amplification. 
Tumor cell nuclei contain numerous green Eag1 signals, but only few reference signals in 
red (centromer 1; x1000). Nuclei counterstained with DAPI (blue). D) Impact of Eag1 gene 
amplification on overall survival in surgically resected colorectal adenocarcinoma. 
 
Expression of Eag1 protein was analysed in isolated crypt cells from patients, diagnosed with 
sigma diverticulitis, ulcerative colitis, colorectal adenocarcinoma, coecum carcinoma and 
colonic neoplasm (Fig. 4-5C). Samples were also obtained from patients with unrelated 
diseases, such as cystic fibrosis. No expression of Eag1 was detected in these samples. The 
variability of the tissue sample quality was assessed by simultaneous detection of ß-actin 
expression. In summary, expression of Eag1 was detected in most carcinomas and in some 
patients diagnosed with diverticulitis, while the healthy colon does not seem to express cell 
cycle regulated K+ channels (Fig. 4-5B). 
 
The Eag1 gene is amplified in tumor specimens and is associated with adverse 
outcome 
pTNM stage, histological grade, and UICC stage were strongly associated with overall 
survival (p<0.0001 each; data not shown). FISH analysis showed amplification of the Eag1 
gene in 13 (3.4%) of the 386 tumor specimens (Table 4-2). A representative case with Eag1 
amplification is shown in figure 4-5C. Univariate survival analysis revealed that Eag1 
amplification was significantly associated with adverse outcome (p=0.0202; Fig. 4-5D). If 
entered in a multivariate model (Cox proportional hazard), amplification of Eag1 emerged as 
an independent prognostic marker (p=0.0126, RR=3.55) together with UICC stage 
(p<0.0001, RR 15.56) and histological grade (p=0.0167, RR 1.77, n=386). Thus expression 
of Eag1 is associated with reduced overall survival in patients with colonic carcinoma. 
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Table 4-2 Clinicopathologic characteristics of colorectal adenocarcinomas (n=386) 
 
 
male 
 
200 (48.1%) 
 
sex  
female 186 (51.8%) 
age years (range) 71.6±1.1 (36-96) 
right colon 164 (43.4%) localisation  
left colon 214 (56.6%) 
pT1 7 (1.8%) 
pT2 64 (16.6%) 
pT3 247 (64.0%) 
pT 
pT4 68 (17.6 %) 
pN0 195 (50.5%) 
pN1 107 (28.2%) 
pN  
pN2 84 (27.7%) 
pM0 309 (80.1%) pM  
pM1 77 (19.9%) 
I 53 (13.7%) 
II 129 (33.4%) 
III 127 (32.9%) 
stage  
IV 77 (20.0%) 
G1 2 (0.5%)) 
G2 290 (75.1%) 
grading  
G3 94 (24.4%)  
follow-up (months) mean (range) 37.7±3.4 (0-140) 
 median 
 
31.0 
 
Discussion 
 
Effects of pro-inflammatory and carcinogenic chemicals 
For the present study, we used the mouse C57BL/6N strain, which shows a high incidence of 
colorectal tumors after DMH treatment (117, 118). Histological changes were identified early 
after DMH injection; however, definite cancers develop typically only after 24 weeks of 
treatment (118). Intrarectal infusion of MNU yielded a high incidence (up to 100%) of colonic 
cancer in previous studies with shrews (119). We detected initial inflammatory responses in 
both DMH and MNU treated animals, similar to the inflamed (DSS) colon. However at later 
stages, carcinogens caused significant changes in mucosal architecture and expression of 
Kv3.1, Kv1.3 and Kv1.5 and particularly Eag channels. This was not observed in the DSS 
model. Thus, expression oncogenic Eag channels appear to be a consequence of the 
carcinogen treatment and not simply a result from inflammation. This channel was also found 
in human colonic cancers, but not in normal tissues. It suggests that Eag has an oncogenic 
potential in the colonic epithelium. Interestingly, Eag was also detected in diverticulitis, which 
has the potential to change into colonic cancer. We hypothesize that expression of Eag in 
pre-neoplastic tissues supports malignancy and may drive the development towards colonic 
cancer. 
 
Electrolyte transport changes during carcinogenesis and colitis 
Several reports show altered electrolyte transport in early stages of tumor development. 
Using the present models, we confirm reduction of amiloride sensitive Na+ absorption by 
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treatment with DMH, MNU and DSS. Inhibition of amiloride sensitive Na+ absorption was not 
explained by changes in the expression profile of the three Na+ channel subunits. A likely 
reason for reduced Na+ absorption is an attenuation of the Na+/K+-ATPase in the distal colon 
(120). cAMP induced Cl- secretion was reduced initially, but was up-regulated at later stages 
of DMH treatment. Stool irregularities, with changes from constipation to diarrhea are often 
observed in patients with intestinal tumors or inflammatory bowel disease and the present 
findings may therefore supply an explanation for these symptoms. 
 
Expression of Kv channels during inflammation and carcinogenesis 
Kv channels promote cell proliferation and support tumor development (103, 104). In 
multiplex RT-PCR, we found enhanced expression of the channels Kv1.3, Kv1.5 and Kv3.1 
(Table 1). Kv1.3 (gene locus KCNA3) is essential for lymphocyte proliferation and supports 
development of cancer in prostate, colon and breast. Kv1.5 (gene locus KCNA5) supports 
proliferation of gastric cancer (102, 121). Moreover, expression of Kv1.5 correlates with the 
grade of malignancy of gliomas (122). The apparent dissociation constants (Kd) of 4-AP for 
Kv1.3, Kv1.5 and Kv3.1 channels are 195 µM, 270 µM and 29 µM respectively, which are in 
the range of the 4-AP concentration (100 µM) used in the present study (123). We suggest 
that Kv3.1 (gene locus KCNC1) is mainly responsible for the 4-AP dependent inhibition of ion 
transport in the malignant colon. Thus, this is the first study, which supplies evidence that 
Kv3.1 channels are involved in development of cancer. Expression of Kv3.1 is normally 
restricted to CNS and to a subpopulation of T lymphocytes (103). Kv3.4, another member of 
this subfamily of Kv channels, controls proliferation of oral and oesophageal squamous 
carcinoma cells (124). 
 
An oncogenic role of Eag channels in the colon 
According to previous reports, expression of Eag1 and Erg1 channels is strictly limited to 
excitable tissues. In contrast, malign epithelial tumors the cell cycle controlled Eag channel 
determines malignancy and metastasis of breast cancer (103, 105, 108, 125). Crypt cells of 
carcinogen treated mice demonstrated expression of Eag1, Erg1 and Elk1 in the present 
study. When normalized to the actin signal, expression of Eag1 was somewhat larger in the 
distal colon when compared to the proximal colon of DMH treated animals. However, the 
difference was not statistically different. Moreover, expression of Eag1 was found in human 
colorectal adenocarcinomas. FISH analysis showed amplification of the Eag1gene in 13 
(3.4%) of the 386 tumor specimens. Eag1 amplification was significantly associated with 
adverse outcome. The low prevalence of Eag1 amplification does not question its 
importance, since mechanisms other than amplification may account for activation and over-
expression in a larger fraction of tumors. For example another potassium channel, KCNK9 at 
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8q24.3, was previously found to be amplified in about 10%, but over expressed in 44% of 
breast cancers (126). 
 
Taken together, carcinogenesis in the colon and colitis change expression of ion channels 
important for salt transport, which is likely to cause stool irregularities. Expression of the cell 
cycle regulated K+ channel Eag1 is closely correlated with malignancy in the human and 
rodent colon and Eag1 gene amplification is associated with reduced surviving rate. These 
data suggested that Eag1 expression is important for tumor development in the human 
colon. Since Eag1 is already expressed at a pre-malignant stage, Eag1 transcripts detected 
in rectal biopsies or stool samples may serve as early diagnostic and prognostic markers, as 
demonstrated recently for cervical cancer (107). The present data may also be useful in 
developing new therapeutic strategies for the treatment of colonic cancer. 
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Chapter 5 
 
 
Upregulation of colonic ion channels in APC-Min/+ mice 
 
Abstract 
 
The adenomatosis polyposis coli (APC) tumor suppressor gene is mutated in almost all 
human colonic cancers. Disturbances in Na+ absorption have been observed in colonic 
cancer and ion channels such as ether a go-go (Eag) or Ca2+ sensitive BK channels have 
been recognized for their oncogenic potential. The APC-Min/+ mouse model is characterized 
by reduced APC expression and multiple intestinal neoplasia (Min). The activity of colonic ion 
channels was assessed by electrophysiological and molecular techniques. APC-Min/+ mice 
developed polyps in proximal and distal colon and experienced a significant weight loss 
during an observation period of 21 weeks. Rectal potential measurements in vivo indicated 
an increase in amiloride sensitive Na+ absorption in APC-Min/+ mice. Quantitative Ussing 
chamber studies demonstrated enhanced Na+ absorption via epithelial Na+ channels (ENaC) 
and suggested enhanced activity of oncogenic BK and Eag1 channels. Patch clamp 
experiments on mid crypt cells showed similar results for APC-Min/+ and wt mice, suggesting 
that changes in channel activity take place in the surface epithelium. ENaC-mRNA and 
membrane protein expression was clearly enhanced in colonic surface epithelial cells. The 
data suggest that reduced expression of the APC gene with upregulation of the downstream 
proteins Akt and mTOR augments the activity of ENaC and oncogenic potassium channels. 
These changes reflect an imbalance due to reduced apoptosis and enhanced mitotic activity, 
and may have implications for the clinical outcome. 
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Introduction 
 
Membrane ion channels have been demonstrated in previous studies to control cell 
proliferation. Changes in ion channel expression during development of cancer have been 
frequently observed (for review see (6)). Ion channel activity determines homeostatic 
parameters such as membrane voltage, intracellular ion concentration, and cell volume. Ion 
channels also control cytosolic pH and cell signaling by changes in the intracellular Ca2+ 
concentration (6, 44, 79). Some ion channels, like Eag1, fulfill specific tasks during the cell 
cycle (19, 41). Voltage gated K+ channels are detected in breast and colonic cancer 
specimens and other malign tumors (16, 19, 41, 44, 60). Large conductance Ca2+ activated 
K+ channels are found in tumors of prostate, breast and colorectum (88, 127). Previous in 
vitro studies demonstrate a contribution of K+ channels to proliferation of colonic cancer cells, 
and experiments performed on animal models suggest an oncogenic role of these K+ 
channels in vivo (60). To fully appreciate the changes in ion channel currents occurring 
during carcinogenesis in the colon, further in vivo studies are required, ideally on a 
genetically well defined mouse model (128). 
Previous studies utilized chemical tumor models in order to assess potential changes in ion 
conductances during carcinogenesis in vivo. Treatment of the animals with carcinogens like 
dimethylhydrazine or N-methyl-N-nitrosourea induce colonic cancer, which is paralleled by 
changes in ion channel expression (60, 129). While these studies supply some insight into 
carcinogenesis in vivo, the drawbacks are individual drug susceptibility and inflammation 
(60). Here we studied a well defined genetic mouse model that is based on a mutation in the 
adenomatous polyposis coli (APC) gene. Heterozygote APC-Min/+ mice develop multiple 
intestinal neoplasia (Min) (128). Mutations in the human APC gene are responsible for 
familial adenomatous polyposis and are found in a large majority of colorectal cancers. We 
found that heterozygous APC-Min/+ animals demonstrate a change in expression of 
epithelial colonic Na+ channels and show an increase in BK and Eag1 channel conductance, 
similar to human colonic carcinoma. 
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Results 
 
Pathology of APC-Min/+ mice 
APC-Min/+ mice demonstrated a normal postnatal development but started to loose weight 
from week 12 on. APC-Min/+ mice reached an age of 21.21 ± 0.81 weeks. By then they lost 
more than 20% weight (23.22 ± 0.8 g; n = 23) compared to wt animals (36.66 ± 1.51 g; n = 
32). Wt animals were sacrificed at an age of 23.3 ± 0.77 weeks. Every APC-Min/+ animal 
had large visible polyps in proximal (0.47 ± 0.2) and distal (2.53 ± 1.0; n = 14) colon, but the 
number of polyps was much higher in small intestine and stomach (27.2 ± 7) (Fig. 5-1A). 
Large intestinal polyps consisted of hyperplastic adenomas, which did not yet show signs of 
malignancy (Fig. 5-1B). 
 
 
 
Fig. 5-1 Mucosal abnormalities in APC-Min/+ mice 
A) Macroscopic aspect of inverted proximal and distal colonic mucosa of wild type (wt) 
and APC-Min/+ mice. Colonic mucosa of APC-Min/+ mice shows several large polyps. B) 
Hematoxylin/eosin staining of a distal colonic polyp from an APC-Min/+ animal. C) 
Staining of β-catenin in unaffected proximal colon of wt and APC-Min/+ mice. D) Confocal 
images of β-catenin in unaffected crypts and a polyp from proximal colon. 
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Although ß-catenin accumulation in crypts of APC-Min/+ animals had been described in 
previously (130), we found similar expression of ß-catenin in wt and APC-Min/+ animals in 
proximal and distal (Fig. 5-1C) colon. Confocal images of ß-catenin staining demonstrate 
regular membrane staining in unaffected small and large intestinal mucosa, while the staining 
was diffuse and cytosolic in the polyps (Fig. 5-1D). 
 
Enhanced Na+ absorption in APC-Min/+ mice 
Rectal potentials were measured in vivo in anesthetized animals aged 9, 15 and 19 weeks, 
using a fine polyethylene catheter (c.f. Methods). From week 15 on, APC-Min/+ animals 
displayed increased lumen negative transrectal potential differences (RPD), when compared 
to wt animals (Fig. 5-2A,B). The RPD was mainly due to amiloride sensitive Na+ absorption 
(RPD, since intrarectal application of amiloride via the catheter collapsed the lumen negative 
RPD. Thus, amiloride sensitive epithelial Na+ absorption is significantly enhanced in APC-
Min/+ animals (Fig. 5-2A,C and Table 5-1). 
 
 
 
Fig. 5-2 Enhanced Na+ absorption APC-Min/+ mice 
A) Original recordings of the rectal potential difference (RPD) measured in wt and APC-
Min/+ mice. Inhibition of ENaC by luminal application of amiloride (am, 20 µM) via the 
catheter reduced RPD, while forskolin (forsk, 2 µM) and barium (Ba, 5 mM) increase the 
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rectal potential difference. ATP (100 µM) induced a brief and transient decrease in RPD 
due to activation of BK K+ channels. B) Summary of RPD measured in wild type (wt) and 
APC-Min/+ mice at 9, 15 and 19 weeks of age. C) Summary of the amount of RPD 
inhibited by amiloride in wild type (wt) and APC-Min/+ mice at 9, 15 and 19 weeks of age. 
Asterisks indicate significant differences compared to control (Student´s t-test). (Number 
of mice) 
 
Table 5-1 Rectal potential difference in wt and APC-Min/+ mice 
Under control conditions (RPD) and changes induced by rectal perfusion of amiloride (20 
µM), forskolin 2 µM), ATP (100 µM), and Ba2+ (5 mM). Asterisks indicate significant 
difference when compared to wt animals. (Number of mice). 
 
 
rectal potential difference (mV) 
9 weeks  15 weeks  20 weeks 
 wt 
(n=22-30) 
APC-Min/+ 
(n=10-19) 
 wt 
(n=19-25) 
APC-Min/+ 
(n=8-14) 
 wt 
(n=2-9) 
APC-Min/+ 
(n=4-5) 
 
RPD -12.27 ± 0.9 -10.86 ± 0.8  -9.78 ± 0.4 -13.52 ± 1.7*  -8.52 ± 0.2 -14.11 ± 2.1* 
RPDamil    7.41 ± 0.9    5.65 ± 0.5   4.06 ± 0.3    9.36 ± 1.6*   4.21 ± 0.6    9.76 ± 2.0* 
RPDforsk    2.39 ± 0.3    2.06 ± 0.4   2.66 ± 0.4    2.16 ± 0.5   3.52 ± 0.5    3.24 ± 0.7 
RPDATP    2.09 ± 0.2    2.04 ± 0.4   1.80 ± 0.3    1.82 ± 0.6   2.02 ± 1.4    1.31 ± 0.2 
RPDBa+    2.38 ± 0.2    2.58 ± 0.3   2.52 ± 0.2    1.66 ± 0.2*   2.27 ± 0.3    2.44 ± 0.7 
 
This was further quantified in continuous recordings of the transepithelial voltage, which is a 
measure for the epithelial transport (Fig. 5-3A). Electrogenic absorption of Na+ by ENaC is 
normally limited to distal colon. However, in APC-Min/+ animals amiloride sensitive Na+ 
transport (short circuit current, Isc) was also detected in the proximal colon (Fig. 5-3B). In 
distal colon of APC-Min/+ animals, Na+ absorption was largely upregulated (Fig. 5-3A,B). 
Other transport properties, like forskolin induced Cl- secretion by the cystic fibrosis 
transmembrane conductance regulator (CFTR) Cl- channel, and Ca2+ activated electrolyte 
transport in the distal colon were similar in APC-Min/+ and normal animals (data not shown). 
 
Expression of oncogenic K+ currents in APC-Min/+ mice 
Expression of cell cycle regulated Eag1 and Ca2+ dependent BK channels has been reported 
for colonic cancer and other malignant tumors (60, 88, 127). Basolateral application of the 
Eag1 inhibitor astemizole (5 µM) inhibited Isc in proximal and distal colon of both APC-Min/+ 
and normal mice, however, astemizole sensitive transport (Isc aste) was augmented in proximal 
colon of APC-Min/+ mice (Fig. 5-3C). 4-aminopyridine (0.1 and 2 mM), which inhibits other 
types of voltage gated K+ channels, had no effect on ion transport (data not shown). Luminal 
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paxillin (5 µM) inhibited K+ secretion via BK channels to the same degree in wt (32.8 ± 12 
µA/cm2; n = 13) and APC-Min/+ (31.9 ± 19 µA/cm2; n = 6) mice, suggesting similar baseline 
activity for BK channels. However, the activator of BK channels NS1619 (10 µM) stimulated 
more K+ secretion in the distal colon of APC-Min/+, when compared to wt animals (Fig. 5-
3D). Moreover, after activation of K+ secretion by carbachol (100 µM), the BK channel 
inhibitor paxillin showed a stronger effect in APC-Min/+ mice (19.5 ± 9.7 µA/cm2; n = 3), 
compared to wt (7.2 ± 3.4 µA/cm2). 
 
 
 
Fig. 5-3 Ion transport in the colon of APC-Min/+ mice. 
A) Original recordings of the transepithelial voltage (Vte) measured in a perfused Ussing 
chamber. In APC-Min/+ mice the effect of amiloride (am, 20 µM) was enhanced compared 
to wt animals. B) Summary of the amiloride sensitive transport (Isc am) in proximal and 
distal colonic mucosa of wt and APC-Min/+ mice. C) Summary of the astemizole sensitive 
transport (Isc aste) in proximal and distal colonic mucosa of wt and APC-Min/+ mice. D) 
Summary of the K+ secretion activated by the BK channel activator NS1619 (10 µM) in 
proximal and distal colonic mucosa of wt and APC-Min/+ mice. Asterisks indicate 
significant differences compared to control (Student´s t-test). (Number of mice). 
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Conductances properties were further examined in patch clamp experiments on mid and 
lower crypt cells (Table 5-2). 
 
Table 5-2 Whole cell conductance (Gm) and membrane voltage (Vm) of epithelial cells 
from colonic crypts of wt mice and APC-Min/+ animals. (Number of mice). 
 
  
Gm (nS) 
  
Vm (mV) 
 wt APC-Min/+  wt APC-Min/+ 
 
proximal colon 
 
2.47 ± 0.41 (29) 
 
2. 34 ± 0.3 (28)  
 
-65.64 ± 2.74 (29) 
 
-66.7 ± 3.26 (28) 
distal colon 2.38 ± 0.24 (27) 3.01 ± 0.35 (37)  -68.71 ± 2.76 (27) -62.87 ± 3.01 (37) 
 
The baseline membrane voltage and conductance properties of epithelial cells from wt and 
APC-Min/+ mice were indistinguishable. We identified two populations of cells with either 
linear or outwardly rectifying whole cell currents (Fig. 5-4). 
 
 
 
Fig. 5-4 Whole cell patch clamp experiments from colonic mid crypt and crypt base 
epithelial cells 
Original current tracings (left panels) and current voltage relationships (right panels) 
suggest cells with linear (A) and outwardly rectifying (B) whole cell currents. 
 
Moreover, cAMP- and Ca2+- activated currents were similar in wt and APC-Min/+, and effects 
of paxillin, astemizole or 4-AP could not be detected (data not shown). Thus, Ca2+ activated 
BK channels and astemizole sensitive Eag1 channels must be expressed in the surface 
epithelium, which confirms previous results (55).  
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Enhanced expression of ENaC in APC-Min/+ 
The large increase in Na+ absorption in the APC-Min/+ colon may be due to an increase in 
ENaC-activity or enhanced expression of the three α-, β-, γ-ENaC subunits. Immunostaining 
of all three ENaC-subunits was performed in proximal and distal colon (Fig. 5-5A,B).  
 
 
 
Fig. 5-5 Expression of ENaC in the colon of APC-Min/+ mice 
Expression of α-, β-, and γ-subunits of the epithelial Na+ channel ENaC in proximal (A) 
and distal colon (B) of wt and APC-Min/+ mice. No staining was obtained in the absence 
of primary antibodies (con). C,D) Summary of the results from real time PCR analysis 
indicates upregulation of mRNA expression for βENaC and γENaC in proximal and distal 
colon of APC-Min/+ and control mice. Asterisks indicate significant differences compared 
to control (Student´s t-test). (Number of mice). 
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In contrast to wt-animals α,β,γ-ENaC were clearly detectable in proximal colon of APC-Min/+ 
mice (Fig. 5-5A), and in the distal colon of APC-Min/+ mice expression of α,β,γ-ENaC was 
enhanced when compared to wt animals (Fig. 5-5B). Thus, enhanced Na+ transport in the 
colon of APC-Min/+ mice is due to an increase in ENaC expression. Quantitative real time 
PCR analysis indicated enhanced expression of mRNA for β- and γ-ENaC in proximal and 
distal colon of APC-Min/+ mice (Fig. 5-5C,D). Quantification of total protein prepared from 
isolated colonic crypts, showed an increase in γ-ENaC protein expression in proximal and 
distal colon of APC-Min/+ mice (Fig. 5-6A,B,C). 
 
 
 
Fig. 5-6 Expression of ENaC in the colon of APC-Min/+ mice 
A) Western blot analysis of the three α-, β-, and γ-subunits of the epithelial Na+ channel 
ENaC in isolated distal colonic crypts. B,C) Summary of the expression of α-, β-, and γ-
ENaC in proximal and distal colon of wt and APC-Min/+ mice. Asterisks indicate significant 
differences compared to control (Student´s t-test). (Number of mice). 
 
Upregulation of the protein kinase B (Akt) in tumors of APC-Min/+ mice has been reported 
previously, and patients with colorectal carcinoma have elevated levels of Akt and 
cytoplasmic ß-catenin (131, 132). Because Akt could increase ENaC activity (133), ENaC 
could be upregulated in the colon of APC-Min/+ mice due to an increase in phospho-Akt. 
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Western blot analysis indicated upregulation of activated Akt-P-Thr308 (p-Akt) in APC-Min/+ 
mice in tumor tissues (polyp), but not in unaffected colonic mucosa (crypt) of APC-Min/+ and 
wt mice (Fig. 5-7A), suggesting that Akt may play a minor role in activating ENaC in APC-
Min/+ mice. 
 
 
 
Fig. 5-7 Expression of Akt, Eag1 and BK in the colonic epithelium of APC-Min/+ mice 
A) Western blot analysis of Akt and activated phospho-Akt (Akt-P-Thr308) in unaffected 
mucosa and polyps. B) Results from quantitative analysis of mRNA expression for Eag1 
and α/β subunits of BK channels in isolated crypts from distal colon. C) Western blot 
analysis of expression of Eag1 protein in isolated crypts from proximal and distal colon 
and D) quantitative comparison between wild type and APC-Min/+ mice. Asterisks indicate 
significant differences compared to control (Student´s t-test). (Number of mice).  
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Enhanced K+ channel activity in APC-Min/+ mice is not due to upregulation of BKα or 
Eag1 
Currents through voltage gated Eag1 and large conductance Ca2+ activated BK channels are 
enhanced in the colon of APC-Min/+ mice (Fig. 5-3D). Using real time RT-PCR, we found no 
increase in mRNA expression of the channel forming BKα subunit or Eag1 in APC-Min/+ 
mice (Fig. 5-7B). Similarly, expression of Eag1 protein was unchanged in APC-Min/+ animals 
(Fig. 5-7C,D), and no obvious difference was found for BKα localized in the membrane of 
colonic crypt cells of wt and APC-Min/+ (supplement 4). However, for BK channels the 
regulatory β1- and β2-subunits were found to be upregulated in the distal colon of APC-Min/+ 
mice (Fig. 5-7B), which probably explains the enhanced Ca2+ activated K+ currents in the 
distal colon of APC-Min/+ mice (Fig. 5-3D). 
 
Discussion 
 
Mutations in the APC gene reduce apoptosis and cause colonic cancer 
According to the classical Knudson’ two hit model both alleles of a tumor suppressor gene 
need to be mutated to trigger cancer. In contrast haploinsufficieny predicts a gene dosage 
effect along with additional oncogenic mutations, loss of tumor suppressors or epigenetic 
changes that are required for tumor formation (134). Heterozygous mutations in the gene 
encoding the adenomatosis polyposis coli (APC) protein are found at early stages of 
sporadic colorectal cancers, and are the cause for familial adenomatosis polyposis (135, 
136). APC has a clear role in mediating phosphorylation and degradation of ß-catenin. 
Consequently loss of APC leads to accumulation of ß-catenin at adherens junctions and 
reduced ability of epithelial cells to traverse the crypts. APC mutations inhibit apoptosis by 
allowing constitutive survivin expression. Thus the cells remain in the crypts for an extended 
period of time, with the potential to receive additional toxic signals (137). Genetic instability of 
those crypt cells is reflected by a high anaphase bridge index with enhanced tolerance (136, 
138).  
 
APC-Min reduced apoptosis and enhanced Na+ absorption 
We analyzed changes in colonic ion transport occurring in heterozygous APC-Min/+ mice, 
since previous reports suggested a role of ion channels for cell proliferation and tumor 
formation (6). The remarkable upregulation of colonic Na+ absorption in APC-Min/+ animals 
may be due to several reasons. i) Obviously the mammalian target of the rapamycin (mTOR) 
pathway is upregulated in APC-Min/+, which may lead to enhanced transcription of α,β,γ-
ENaC subunits (139). Notably in preliminary experiments with APC-Min/+ animals, which 
received the mTOR inhibitor rapamycin Na+ absorption and abnormal K+ channel expression 
was abolished (unpublished from the authors laboratory). ii) Although cytosolic accumulation 
Upregulation of colonic ion channels in APC-Min/+ mice 76
 
of ß-catenin and Akt-p-Thr308 were only observed in adenomas (130, 131), low levels of Akt-
p-Thr308 in normal crypts of APC-Min/+ mice may contribute to enhanced ENaC activity, due 
to a mechanism that involves phosphorylation of the ubiquitin ligase Nedd4-2 by Akt (133). 
iii) Expression of ENaC increases with differentiation and aging of the cells present in the 
surface epithelium. Reduced apoptosis in APC-Min/+ may expand the pool of ENaC 
expressing epithelial cells in the surface epithelium and the upper crypt. 
 
Role of Na+ absorption in colonic cancer 
In the present study the animals received a chow enriched with highly saturated lipids, known 
to promote epithelial lesions and neoplasia (140). High fat/low fiber diet is often accompanied 
by constipation representing another cancer promoting factor (141), although the role of 
chronic constipation for cancer development is discussed controversially (142, 143). On the 
other hand, colonic polyposis and colorectal cancer is often accompanied by stool 
irregularities and constipation (144). The augmented Na+ absorption in APC-Min/+ mice is 
likely to cause dehydration of the feces and constipation. Occasionally we observed 
symptoms of intestinal occlusion and rectal prolaps in APC-Min/+ animals. Another mouse 
model of colonic carcinogenesis that made use of chemical carcinogens, also produced 
enhanced Na+ absorption (145). However reduced Na+ absorption has been found during 
acute application of the carcinogens, probably due to induction of an inflammation (60, 129). 
Colonic inflammation like in ulcerative colitis has been shown to reduce electrogenic Na+ 
transport and ENaC expression (146, 147). 
 
Enhanced Eag1 and Ca2+ activated K+ currents in APC-Min/+ mice 
Apart from the change in Na+ absorption, we present evidence for upregulation of potassium 
currents in the colonic epithelium of APC-Min/+ mice. These Eag1 and BK channels were 
shown to support proliferation of colonic cancer cells in vitro, and are expressed in samples 
of human colorectal cancer as well as colonic epithelium of carcinogen treated mice (6, 16, 
41, 44, 60, 88). The present results provide further evidence for a contribution of K+ currents 
to development of cancer (6). How are these channels activated by APC, since we did not 
detect a change in transcripts or total protein for Eag1. It is likely that Eag1 is regulated by ß-
catenin or Akt, since a close member of the same family of voltage gated K+ channels, Erg, 
has been shown to be activated by Akt (148). It is know that mutations in the APC gene alter 
cell cycle regulation, probably through upregulation of Erk-signaling (149). Since Eag1 is a 
cell cycle regulated K+ channel, it is likely that these changes affect Eag1 activity.  
 
Upregulation of Akt may also increase the activity of Ca2+ activated K+ cannels, since 
membrane trafficking of BK channels was shown to be enhanced by Akt in a PI3-kinase 
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dependent manner in neurons (150). PI3-kinase dependent regulation of BK was also found 
in mouse distal colon (55). Apart from that BKβ1 and BKβ2 subunits were largely increased 
in the distal colon of APC-Min/+ animals (Fig. 5-7). Both channel subunits are known to 
increase apparent Ca2+ and estradiol sensitivity of BK channels (151). Taken together, 
enhanced activity of cell cycle regulated Eag1 channels and large conductance Ca2+ 
activated K+ channels are closely correlated with malignancy, and are associated with 
adverse outcome and reduced overall survival of patients (60). Thus the present results may 
provide a basis for new therapeutic strategies for the treatment of colonic cancer. 
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PTP protein tyrosine phosphatase 
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RNA ribonucleic acid 
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S DNA synthesis phase 
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SAMP serine arginine methionine proline 
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